BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 23, Issue 47
This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (29256)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-5) series.
Item 
Count 
PDF2969
WORD355
HTML21966
Figures (1-5)202
 Sum=25492
Featured Article
The chart showing Browse series, Download series.
Item 
Count 
Browse589
Download505
 Sum=1094
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse1266
Download1404
 Sum=2670
Dec 21, 2017 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Perumpail BJ, Khan MA, Yoo ER, Cholankeril G, Kim D, Ahmed A. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease. World J Gastroenterol 2017; 23(47): 8263-8276 [PMID: 29307986 DOI: 10.3748/wjg.v23.i47.8263]
URL: https://www.wjgnet.com/2220-3214/full/v23/i47/8263.htm
Number Citing Articles
1
Nahum Méndez-Sánchez, Eira Cerda-Reyes, Fátima Higuera-de-la-Tijera, Ana K. Salas-García, Samantha Cabrera-Palma, Guillermo Cabrera-Álvarez, Carlos Cortez-Hernández, Luis A Pérez-Arredondo, Emma Purón-González, Edgar Coronado-Alejandro, Arturo Panduro, Heriberto Rodríguez-Hernández, Vania C. Cruz-Ramón, Alejandro Valencia-Rodríguez, Xingshun Qi, Nashla Hamdan-Pérez, Nancy E. Aguilar-Olivos, Beatriz Barranco-Fragoso, Oscar Ramírez-Pérez, Alfonso Vera-Barajas. Dyslipidemia as a risk factor for liver fibrosis progression in a multicentric population with non-alcoholic steatohepatitis. F1000Research 2020; 9: 56 doi: 10.12688/f1000research.21918.1
2
Eveline Gart, Wim van Duyvenvoorde, Martien P. M. Caspers, Nikki van Trigt, Jessica Snabel, Aswin Menke, Jaap Keijer, Kanita Salic, Martine C. Morrison, Robert Kleemann. Intervention with isoleucine or valine corrects hyperinsulinemia and reduces intrahepatic diacylglycerols, liver steatosis, and inflammation in Ldlr−/−.Leiden mice with manifest obesity‐associated NASH . The FASEB Journal 2022; 36(8) doi: 10.1096/fj.202200111R
3
Plator Memaj, Zayd Ouzerara, François R. Jornayvaz. Role of Oxidative Stress and Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 in Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2023; 24(14): 11271 doi: 10.3390/ijms241411271
4
Brian A. Telfer, Viksit Kumar, Aaron D. Aguirre, Anthony E. Samir, Laura J. Brattain. Machine Learning in Cardiovascular Medicine. 2021; : 177 doi: 10.1016/B978-0-12-820273-9.00008-7
5
Yi-Shu Chen, Dan Chen, Chao Shen, Ming Chen, Chao-Hui Jin, Cheng-Fu Xu, Chao-Hui Yu, You-Ming Li. A novel model for predicting fatty liver disease by means of an artificial neural network. Gastroenterology Report 2021; 9(1): 31 doi: 10.1093/gastro/goaa035
6
Fatemeh Mohtashaminia, Mohammad Reza Amini, Fatemeh Sheikhhossein, Kurosh Djafarian, Sakineh Shab-Bidar. Effects berberine–silymarin on liver enzymes: A systematic review and meta-analysis of randomized controlled trials. Clinical Nutrition ESPEN 2022; 49: 181 doi: 10.1016/j.clnesp.2022.01.037
7
Risa M. Wolf, Kiyoko Oshima, Joseph K. Canner, Kimberley E. Steele. Impact of a preoperative low-calorie diet on liver histology in patients with fatty liver disease undergoing bariatric surgery. Surgery for Obesity and Related Diseases 2019; 15(10): 1766 doi: 10.1016/j.soard.2019.08.013
8
Noha M. Hany, Sanaa Eissa, Manal Basyouni, Amany H. Hasanin, Yasmin M. Aboul-Ela, Nagwa M. Abo Elmagd, Iman F. Montasser, Mahmoud A. Ali, Paul J. Skipp, Marwa Matboli. Modulation of hepatic stellate cells by Mutaflor® probiotic in non-alcoholic fatty liver disease management. Journal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-022-03543-z
9
Tao Jiang, Xiao-jing Guo, Li-ping Tu, Zhou Lu, Ji Cui, Xu-xiang Ma, Xiao-juan Hu, Xing-hua Yao, Long-tao Cui, Yong-zhi Li, Jing-bin Huang, Jia-tuo Xu. Application of computer tongue image analysis technology in the diagnosis of NAFLD. Computers in Biology and Medicine 2021; 135: 104622 doi: 10.1016/j.compbiomed.2021.104622
10
Salvatore Petta, Jie Ting, Stefania Saragoni, Luca Degli Esposti, Sanatan Shreay, Maria Letizia Petroni, Giulio Marchesini. Healthcare resource utilization and costs of nonalcoholic steatohepatitis patients with advanced liver disease in Italy. Nutrition, Metabolism and Cardiovascular Diseases 2020; 30(6): 1014 doi: 10.1016/j.numecd.2020.02.016
11
Idrees Suliman, Noha Abdelgelil, Farah Kassamali, Tarek I. Hassanein. The Effects of Hepatic Steatosis on the Natural History of HBV Infection. Clinics in Liver Disease 2019; 23(3): 433 doi: 10.1016/j.cld.2019.05.001
12
Saleh A. Alqahtani, Pegah Golabi, James M. Paik, Brian Lam, Amir H. Moazez, Hazem A. Elariny, Zachary Goodman, Zobair M. Younossi. Performance of Noninvasive Liver Fibrosis Tests in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease. Obesity Surgery 2021; 31(5): 2002 doi: 10.1007/s11695-020-04996-1
13
Jill Roberts Hobbs, Kimberly Ellison Wilson. Obesity in Primary Care: A Case of Endocrine-Associated Conditions. The Journal for Nurse Practitioners 2023; 19(3): 104489 doi: 10.1016/j.nurpra.2022.10.018
14
Libby Stein, Rasham Mittal, Hubert Song, Joanie Chung, Amandeep Sahota. To scan or not to scan: Use of transient elastography in an integrated health system. World Journal of Hepatology 2023; 15(3): 419-430 doi: 10.4254/wjh.v15.i3.419
15
Joshua Tseng, Jeremy Korman, Mazen Noureddin, Daniel Shouhed, James P. Miller, Xiaoxi Feng, Miguel Burch. Routine Versus Selective Liver Biopsy During Bariatric Surgery: Postoperative Outcomes and Preoperative Predictors of NASH. Obesity Surgery 2022; 32(2): 463 doi: 10.1007/s11695-021-05797-w
16
Yu A. An, Shiuhwei Chen, Yingfeng Deng, Zhao V. Wang, Jan-Bernd Funcke, Manasi Shah, Bo Shan, Ruth Gordillo, Jun Yoshino, Samuel Klein, Christine M. Kusminski, Philipp E. Scherer. The mitochondrial dicarboxylate carrier prevents hepatic lipotoxicity by inhibiting white adipocyte lipolysis. Journal of Hepatology 2021; 75(2): 387 doi: 10.1016/j.jhep.2021.03.006
17
Lionel Fizanne, Alexandre Villard, Nadia Benabbou, Sylvain Recoquillon, Raffaella Soleti, Erwan Delage, Mireille Wertheimer, Xavier Vidal‐Gómez, Thibauld Oullier, Samuel Chaffron, M. Carmen Martínez, Michel Neunlist, Jérôme Boursier, Ramaroson Andriantsitohaina. Faeces‐derived extracellular vesicles participate in the onset of barrier dysfunction leading to liver diseases. Journal of Extracellular Vesicles 2023; 12(2) doi: 10.1002/jev2.12303
18
Xiangmeng Chen, Teng Ma, Rowena Yip, Ponni V. Perumalswami, Andrea D. Branch, Sara Lewis, Michael Crane, David F. Yankelevitz, Claudia I. Henschke. Elevated prevalence of moderate-to-severe hepatic steatosis in World Trade Center General Responder Cohort in a program of CT lung screening. Clinical Imaging 2020; 60(2): 237 doi: 10.1016/j.clinimag.2019.12.009
19
Nan Xu, Huijuan Luo, Minyao Li, Jiazhen Wu, Xue Wu, Liping Chen, Yuxuan Gan, Fengkun Guan, Mengyao Li, Ziren Su, Jiannan Chen, Yuhong Liu. β-patchoulene improves lipid metabolism to alleviate non-alcoholic fatty liver disease via activating AMPK signaling pathway. Biomedicine & Pharmacotherapy 2021; 134: 111104 doi: 10.1016/j.biopha.2020.111104
20
Ahmed M Baradeiya, Khaled M Taghlabi, Abdelhalim N Saleh, Sindhura Manikonda, Siffat S Salim. Can Nutritional Supplements Benefit Patients With Nonalcoholic Steatohepatitis and Nonalcoholic Fatty Liver Disease?. Cureus 2023;  doi: 10.7759/cureus.40849
21
Salvatore Corrao, Giuseppe Natoli, Christiano Argano. Nonalcoholic fatty liver disease is associated with intrahepatic cholangiocarcinoma and not with extrahepatic form: definitive evidence from meta-analysis and trial sequential analysis. European Journal of Gastroenterology & Hepatology 2021; 33(1): 62 doi: 10.1097/MEG.0000000000001684
22
Shantan Cheemerla, Maya Balakrishnan. Global Epidemiology of Chronic Liver Disease. Clinical Liver Disease 2021; 17(5): 365 doi: 10.1002/cld.1061
23
Yiwei Hang, Christine Lee, Youssef M Roman. Assessing the clinical utility of major indices for nonalcoholic fatty liver disease in East Asian populations. Biomarkers in Medicine 2023; 17(8): 445 doi: 10.2217/bmm-2023-0172
24
Hafiza Madiha Jaffar, Fahad Al‐Asmari, Faima Atta Khan, Muhammad Abdul Rahim, Eliasse Zongo. Silymarin: Unveiling its pharmacological spectrum and therapeutic potential in liver diseases—A comprehensive narrative review. Food Science & Nutrition 2024;  doi: 10.1002/fsn3.4010
25
Natalia Vallianou, Gerasimos Socrates Christodoulatos, Irene Karampela, Dimitrios Tsilingiris, Faidon Magkos, Theodora Stratigou, Dimitris Kounatidis, Maria Dalamaga. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives. Biomolecules 2021; 12(1): 56 doi: 10.3390/biom12010056
26
Ji‐Mu Wu, Getu Zhaori, Li Mei, Xiao‐Man Ren, Arong Tong Laga, Batu Deligen. Plantamajoside modulates immune dysregulation and hepatic lipid metabolism in rats with nonalcoholic fatty liver disease viaAMPK/Nrf2 elevation. The Kaohsiung Journal of Medical Sciences 2023; 39(8): 801 doi: 10.1002/kjm2.12712
27
Liuxin Zhang, Mengting Zhang, Min Wang, Minxian Wang, Ru Zhang, Hongliang Wang, Wei Zhang, Yajie Ding, Jie Wang. External validation and comparison of simple tools to screen for nonalcoholic fatty liver disease in Chinese community population. European Journal of Gastroenterology & Hepatology 2022; 34(8): 865 doi: 10.1097/MEG.0000000000002399
28
Ifrath Parveen, Archana Prabhat. Energy Intake and Lifestyle Risk Factors among Non Alcoholic Fatty Liver Disease Patients. The Indian Journal of Nutrition and Dietetics 2020; : 308 doi: 10.21048/ijnd.2020.57.3.25563
29
Yuwei Wu, Jinyu Wang, Xiaodong Zheng, Yongyan Chen, Mei Huang, Qiang Huang, Weihua Xiao, Haiming Wei, Zhigang Tian, Rui Sun, Cheng Sun. Establishment and Preclinical Therapy of Patient-derived Hepatocellular Carcinoma Xenograft Model. Immunology Letters 2020; 223: 33 doi: 10.1016/j.imlet.2020.04.009
30
Dajana Lichtenstein, Claudia Luckert, Jimmy Alarcan, Georges de Sousa, Michail Gioutlakis, Efrosini S. Katsanou, Parthena Konstantinidou, Kyriaki Machera, Emanuela S. Milani, Ad Peijnenburg, Roger Rahmani, Deborah Rijkers, Anastasia Spyropoulou, Marianna Stamou, Geert Stoopen, Shana J. Sturla, Bernd Wollscheid, Nathalie Zucchini-Pascal, Albert Braeuning, Alfonso Lampen. An adverse outcome pathway-based approach to assess steatotic mixture effects of hepatotoxic pesticides in vitro. Food and Chemical Toxicology 2020; 139: 111283 doi: 10.1016/j.fct.2020.111283
31
Yangjun Liu, Wei Xie, Juan Li, Zbigniew Ossowski. Effects of aerobic exercise on metabolic indicators and physical performance in adult NAFLD patients: A systematic review and network meta-analysis. Medicine 2023; 102(14): e33147 doi: 10.1097/MD.0000000000033147
32
Simona Alexandra Iacob, Diana Gabriela Iacob. Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.814209
33
Somaya Albhaisi, Arun Sanyal. Recent advances in understanding and managing non-alcoholic fatty liver disease. F1000Research 2018; 7: 720 doi: 10.12688/f1000research.14421.1
34
Hanui Jo, Lipjung Jung, Nuri Kim, Gi-Wook Kim, Dongwon Lee. Bile acid-based polydrug nanoparticles for the treatment of acute liver injury. Macromolecular Research 2024;  doi: 10.1007/s13233-023-00241-7
35
Reem Al-Qarni, Muhammad Iqbal, Maram Al-Otaibi, Faisal Al-Saif, Assim A. Alfadda, Hisham Alkhalidi, Fahad Bamehriz, Mazen Hassanain. Validating candidate biomarkers for different stages of non-alcoholic fatty liver disease. Medicine 2020; 99(36): e21463 doi: 10.1097/MD.0000000000021463
36
Oscar Danielsson, Jana Nano, Katja Pahkala, Susanne Rospleszcz, Terho Lehtimäki, Christopher L. Schlett, Mika Kähönen, Fabian Bamberg, Olli Raitakari, Annette Peters, Markku J. Nissinen, Fredrik O. Åberg. Validity of fatty liver disease indices in the presence of alcohol consumption. Scandinavian Journal of Gastroenterology 2022; 57(11): 1349 doi: 10.1080/00365521.2022.2085060
37
Seoung-Woo Lee, Su-Min Baek, Kyung-Ku Kang, A-Rang Lee, Tae-Un Kim, Seong-Kyoon Choi, Yoon-Seok Roh, Il-Hwa Hong, Sang-Joon Park, Tae-Hwan Kim, Kyu-Shik Jeong, Jin-Kyu Park. Vitamin C Deficiency Inhibits Nonalcoholic Fatty Liver Disease Progression through Impaired de Novo Lipogenesis. The American Journal of Pathology 2021; 191(9): 1550 doi: 10.1016/j.ajpath.2021.05.020
38
Joise Teixeira, Cláudio Augusto Marroni, Paula Rosales Zubiaurre, Ana Henz, Lais Faina, Lilian Kethelyn Pinheiro, Claudio Cora Mottin, Sabrina Alves Fernandes. Phase angle and non-alcoholic fatty liver disease before and after bariatric surgery. World Journal of Hepatology 2020; 12(11): 1004-1019 doi: 10.4254/wjh.v12.i11.1004
39
Guoqing Huang, Qiankai Jin, Yushan Mao. Predicting the 5-Year Risk of Nonalcoholic Fatty Liver Disease Using Machine Learning Models: Prospective Cohort Study. Journal of Medical Internet Research 2023; 25: e46891 doi: 10.2196/46891
40
Jian Ju, Mozaniel Santana de Oliveira, Yu Qiao. Cinnamon: A Medicinal Plant and A Functional Food Systems. Food Bioactive Ingredients 2023; : 231 doi: 10.1007/978-3-031-33505-1_16
41
Evgeniy V. Kryukov, Dmitry V. Cherkashin, Vladimir V. Saluhov, Konstantin V. Matjushenko, Aleksey D. Sobolev, Nikolaj N. Shcherbina. Extrahepatic manifestations of chronic viral hepatitis C. Bulletin of the Russian Military Medical Academy 2022; 24(2): 341 doi: 10.17816/brmma103982
42
Yimeng Shu, Guoqing Huang, Yushan Mao. The Metabolic Score for Insulin Resistance Index is Superior to the Triglyceride and Glucose Index in Identifying Nonalcoholic Fatty Liver Disease in Hyperuricemia Subjects. Diabetes, Metabolic Syndrome and Obesity 2023; : 4235 doi: 10.2147/DMSO.S438975
43
Sara Jarmakiewicz-Czaja, Aneta Sokal, Piotr Pardak, Rafał Filip, Alessandro Granito. Glucocorticosteroids and the Risk of NAFLD in Inflammatory Bowel Disease. Canadian Journal of Gastroenterology and Hepatology 2022; 2022: 1 doi: 10.1155/2022/4344905
44
Jamie O'Hara, Alan Finnegan, Harpal Dhillon, Leonardo Ruiz-Casas, Gabriel Pedra, Bethany Franks, George Morgan, Vanessa Hebditch, Bengt Jönsson, Mzwandile Mabhala, Tatjana Reic, Ingo Van Thiel, Vlad Ratziu, Manuel Romero-Gomez, Elisabetta Bugianesi, Jörn M. Schattenberg, Quentin M. Anstee. Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study. JHEP Reports 2020; 2(5): 100142 doi: 10.1016/j.jhepr.2020.100142
45
Seungtae On, Hyun Young Kim, Hyo Seon Kim, Jeongwoo Park, Keon Wook Kang. Involvement of G-Protein-Coupled Receptor 40 in the Inhibitory Effects of Docosahexaenoic Acid on SREBP1-Mediated Lipogenic Enzyme Expression in Primary Hepatocytes. International Journal of Molecular Sciences 2019; 20(11): 2625 doi: 10.3390/ijms20112625
46
Peter M. Graffy, Veit Sandfort, Ronald M. Summers, Perry J. Pickhardt. Automated Liver Fat Quantification at Nonenhanced Abdominal CT for Population-based Steatosis Assessment. Radiology 2019; 293(2): 334 doi: 10.1148/radiol.2019190512
47
Sang Joon An, Eun-Jung Yang, Subin Oh, Kyong Jin Park, Taehyen Kim, Yeon-pyo Hong, Yun-Jung Yang. The association between urinary bisphenol A levels and nonalcoholic fatty liver disease in Korean adults: Korean National Environmental Health Survey (KoNEHS) 2015-2017. Environmental Health and Preventive Medicine 2021; 26(1) doi: 10.1186/s12199-021-01010-7
48
Sayma Yaqub, Patricia Ananias, Arpita Shah, Kanita Luenam, Arunima Mariya Jose, Joao Pedro Melo, Arifa Turkistani, Lubna Mohammed. Decoding the Pathophysiology of Non-alcoholic Fatty Liver Disease Progressing to Non-alcoholic Steatohepatitis: A Systematic Review. Cureus 2021;  doi: 10.7759/cureus.18201
49
Atsuhiro Nagasaki, Shinnichi Sakamoto, Toshiki Arai, Minami Kato, Eri Ishida, Hisako Furusho, Makiko Fujii, Takashi Takata, Mutsumi Miyauchi. Elimination of Porphyromonas gingivalis inhibits liver fibrosis and inflammation in NASH. Journal of Clinical Periodontology 2021; 48(10): 1367 doi: 10.1111/jcpe.13523
50
Isabel Hidalgo, Miguel Ortiz-Flores, Francisco Villarreal, Salvador Fonseca-Coronado, Guillermo Ceballos, Eduardo Meaney, Nayelli Nájera. Is it possible to treat nonalcoholic liver disease using a flavanol-based nutraceutical approach? Basic and clinical data. Journal of Basic and Clinical Physiology and Pharmacology 2022; 33(6): 703 doi: 10.1515/jbcpp-2021-0285
51
Manca Povsic, On Yee Wong, Richard Perry, Juliana Bottomley. A Structured Literature Review of the Epidemiology and Disease Burden of Non-Alcoholic Steatohepatitis (NASH). Advances in Therapy 2019; 36(7): 1574 doi: 10.1007/s12325-019-00960-3
52
Sejeong Lee, Jaehyun Bae, Seung Up Kim, Minyoung Lee, Yong-ho Lee, Eun Seok Kang, Bong-Soo Cha, Byung-Wan Lee. Intact ketogenesis predicted reduced risk of moderate-severe metabolic-associated fatty liver disease assessed by liver transient elastography in newly diagnosed type 2 diabetes. Frontiers in Endocrinology 2024; 14 doi: 10.3389/fendo.2023.1306134
53
Jose Hernandez Roman, Samarth Patel. Why Do Lifestyle Recommendations Fail in Most Patients with Nonalcoholic Fatty Liver Disease?. Gastroenterology Clinics of North America 2020; 49(1): 95 doi: 10.1016/j.gtc.2019.10.001
54
Pang-Yen Liu, Yu-Kai Lin, Kai-Wen Chen, Kun-Zhe Tsai, Yen-Po Lin, Eiki Takimoto, Gen-Min Lin. Association of Liver Transaminase Levels and Long-Term Blood Pressure Variability in Military Young Males: The CHIEF Study. International Journal of Environmental Research and Public Health 2020; 17(17): 6094 doi: 10.3390/ijerph17176094
55
Daria A. Teplyuk, Aliya A. Kaisina, Shabnam I. Ibragimova, Afina A. Bestavashvili, Irina O. Tinkova, Evgeniia Iu. Pashkova, Jamilya A. Kaibullayeva, Alexander V. Nersesov, Chavdar S. Pavlov. Non-alcoholic fatty liver disease: from understanding risk factors to finding optimal treatment regimens: A review. Consilium Medicum 2023; 25(5): 325 doi: 10.26442/20751753.2023.5.202272
56
Xianwen Chen, Junnan Shi, Yunfeng Lai, Yan Xue, Carolina Oi Lam Ung, Hao Hu. Systematic analysis of randomised controlled trials of Chinese herb medicine for non-alcoholic steatohepatitis (NASH): implications for future drug development and trial design. Chinese Medicine 2023; 18(1) doi: 10.1186/s13020-023-00761-5
57
Hyun Ho Jo, Changwook Min, Dae-Sung Kyoung, Min-Ae Park, Sang Gyune Kim, Young Seok Kim, Young Chang, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Hong Soo Kim, Baek Gyu Jun, Young Don Kim, Gab Jin Cheon, Jeong-Ju Yoo, Chun Chieh Yeh. Adverse outcomes after surgeries in patients with liver cirrhosis among Korean population: A population-based study. PLOS ONE 2021; 16(6): e0253165 doi: 10.1371/journal.pone.0253165
58
Andrea Gonzalez, Mayalen Valero-Breton, Camila Huerta-Salgado, Oscar Achiardi, Felipe Simon, Claudio Cabello-Verrugio. Impact of exercise training on the sarcopenia criteria in non-alcoholic fatty liver disease: a systematic review and meta-analysis. European Journal of Translational Myology 2021;  doi: 10.4081/ejtm.2021.9630
59
Takahiro Iwasaki, Akiko Hirose, Tetsuji Azuma, Tamie Ohashi, Kazutoshi Watanabe, Akihiro Obora, Fumiko Deguchi, Takao Kojima, Atsunori Isozaki, Takaaki Tomofuji. Correlation between ultrasound-diagnosed non-alcoholic fatty liver and periodontal condition in a cross-sectional study in Japan. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-25857-z
60
Yingying Liu, Xinkui Liu, Wei Zhou, Jingyuan Zhang, Jiarui Wu, Siyu Guo, Shanshan Jia, Haojia Wang, Jialin Li, Yingying Tan. Integrated bioinformatics analysis reveals potential mechanisms associated with intestinal flora intervention in nonalcoholic fatty liver disease. Medicine 2022; 101(36): e30184 doi: 10.1097/MD.0000000000030184
61
Feryal Savari, Seyed Ali Mard. Nonalcoholic steatohepatitis: A comprehensive updated review of risk factors, symptoms, and treatment. Heliyon 2024; 10(7): e28468 doi: 10.1016/j.heliyon.2024.e28468
62
Sangwon F. Kim, Jang Hyun Choi. Metabolic Syndrome. 2023; : 1 doi: 10.1007/978-3-319-12125-3_36-2
63
Liming Liu, Ying Zhou, Dan Dai, Hongmei Xia, Kang Zhao, Jianjun Zhang, Samuel Martins Silvestre. Antifibrotic Effects of Kangxian Ruangan Capsule on Rats with Nonalcoholic Fatty Liver Fibrosis and Hepatic Stellate Cells through Regulation of TGF-β and TLR4 Signaling Pathways. Evidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/5649575
64
Lingxi Kong, Yang Yang, Haidong Li, Youlan Shan, Xin Wang, Xuefeng Shan. Prevalence of nonalcoholic fatty liver disease and the related risk factors among healthy adults: A cross-sectional study in Chongqing, China. Frontiers in Public Health 2023; 11 doi: 10.3389/fpubh.2023.1127489
65
Rebeca Escutia-Gutiérrez, J. Samael Rodríguez-Sanabria, C. Alejandra Monraz-Méndez, Jesús García-Bañuelos, Arturo Santos-García, Ana Sandoval-Rodríguez, Juan Armendáriz-Borunda. Pirfenidone modifies hepatic miRNAs expression in a model of MAFLD/NASH. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-91187-2
66
Maja Szymanska, Daanyaal Mahmood, Timothy E. Yap, Maria F. Cordeiro. Recent Advancements in the Medical Treatment of Diabetic Retinal Disease. International Journal of Molecular Sciences 2021; 22(17): 9441 doi: 10.3390/ijms22179441
67
Ling-Yan Yu, Wei-Ying Li, Jia Lin. Juglanin improves lipid metabolism disorder, liver injury, and intestinal integrity in nonalcoholic fatty liver mice. World Chinese Journal of Digestology 2020; 28(4): 113 doi: 10.11569/wcjd.v28.i4.113
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
68
Cornelius von Morze, Tyler Blazey, Mark S. Conradi. Quantifying Liver Fat Using a Low-Field Unilateral MR System. Applied Magnetic Resonance 2023; 54(11-12): 1365 doi: 10.1007/s00723-023-01595-y
69
Tian-Hao Yuan, Zhen-Sheng Yue, Guo-Heng Zhang, Lin Wang, Guo-Rui Dou. Beyond the Liver: Liver-Eye Communication in Clinical and Experimental Aspects. Frontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.823277
70
Shiwei Li, Yuhong Fu, Yue Liu, Xinxin Zhang, Haijun Li, Lei Tian, Lin Zhuo, Ming Liu, Jingqiu Cui. Serum Uric Acid Levels and Nonalcoholic Fatty Liver Disease: A 2-Sample Bidirectional Mendelian Randomization Study. The Journal of Clinical Endocrinology & Metabolism 2022; 107(8): e3497 doi: 10.1210/clinem/dgac190
71
Cosmas Rinaldi A. Lesmana, Meudia Syahidah, Irsan Hasan, Rino A. Gan. The Role of the Gut Microbiome and its Derived Mediators in Nonalcoholic Fatty Liver Disease. European Medical Journal 2019;  doi: 10.33590/emj/10310251
72
Pijun Yan, Yuru Wu, Xiaofang Dan, Xian Wu, Qian Tang, Xiping Chen, Yong Xu, Jianhua Zhu, Ying Miao, Qin Wan. Aspartate aminotransferase/alanine aminotransferase ratio was associated with type 2 diabetic peripheral neuropathy in a Chinese population: A cross-sectional study. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1064125
73
Daryl Ramai, Waqqas Tai, Michelle Rivera, Antonio Facciorusso, Nicola Tartaglia, Mario Pacilli, Antonio Ambrosi, Christian Cotsoglou, Rodolfo Sacco. Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular Carcinoma. Biomedicines 2021; 9(2): 184 doi: 10.3390/biomedicines9020184
74
Roberta Forlano, Benjamin H. Mullish, Rooshi Nathwani , Ameet Dhar, Mark R. Thursz, Pinelopi Manousou . Non-Alcoholic Fatty Liver Disease and Vascular Disease. Current Vascular Pharmacology 2020; 19(3): 269 doi: 10.2174/1570161118666200318103001
75
Antonio De Vincentis, Zahra Rahmani, Moises Muley, Umberto Vespasiani-Gentilucci, Sergio Ruggiero, Parvin Zamani, Tannaz Jamialahmadi, Amirhossein Sahebkar. Long noncoding RNAs in nonalcoholic fatty liver disease and liver fibrosis: state-of-the-art and perspectives in diagnosis and treatment. Drug Discovery Today 2020; 25(7): 1277 doi: 10.1016/j.drudis.2020.05.009
76
Yinhua Ni, Yufeng Zhao, Lingyan Ma, Zhe Wang, Liyang Ni, Luting Hu, Zhengwei Fu. Pharmacological activation of REV-ERBα improves nonalcoholic steatohepatitis by regulating intestinal permeability. Metabolism 2021; 114: 154409 doi: 10.1016/j.metabol.2020.154409
77
Hideo Ohuchi. What are the mechanisms for FALD and how can we prevent the progression?. International Journal of Cardiology 2018; 273: 121 doi: 10.1016/j.ijcard.2018.09.071
78
Aunchalee Jaroenlapnopparat, Pichatorn Suppakitjanusant, Ben Ponvilawan, Nipith Charoenngam. Vitamin D-Related Genetic Variations and Nonalcoholic Fatty Liver Disease: A Systematic Review. International Journal of Molecular Sciences 2022; 23(16): 9122 doi: 10.3390/ijms23169122
79
Xiaobo Zhang, Rui Gao, Zhen Zhou, Jiayi Sun, Xuehua Tang, Jialiang Li, Xin Zhou, Tao Shen. Uncovering the mechanism of Huanglian-Wuzhuyu herb pair in treating nonalcoholic steatohepatitis based on network pharmacology and experimental validation. Journal of Ethnopharmacology 2022; 296: 115405 doi: 10.1016/j.jep.2022.115405
80
Stefania Di Mauro, Alessandra Scamporrino, Salvatore Petta, Francesca Urbano, Agnese Filippello, Marco Ragusa, Maria T. Di Martino, Francesca Scionti, Stefania Grimaudo, Rosaria M. Pipitone, Graziella Privitera, Antonino Di Pino, Roberto Scicali, Luca Valenti, Paola Dongiovanni, Anna Fracanzani, Agata M. Rabuazzo, Antonio Craxì, Michele Purrello, Francesco Purrello, Salvatore Piro. Serum coding and non‐coding RNAs as biomarkers of NAFLD and fibrosis severity. Liver International 2019; 39(9): 1742 doi: 10.1111/liv.14167
81
Valentina A. Zavala, Paige M. Bracci, John M. Carethers, Luis Carvajal-Carmona, Nicole B. Coggins, Marcia R. Cruz-Correa, Melissa Davis, Adam J. de Smith, Julie Dutil, Jane C. Figueiredo, Rena Fox, Kristi D. Graves, Scarlett Lin Gomez, Andrea Llera, Susan L. Neuhausen, Lisa Newman, Tung Nguyen, Julie R. Palmer, Nynikka R. Palmer, Eliseo J. Pérez-Stable, Sorbarikor Piawah, Erik J. Rodriquez, María Carolina Sanabria-Salas, Stephanie L. Schmit, Silvia J. Serrano-Gomez, Mariana C. Stern, Jeffrey Weitzel, Jun J. Yang, Jovanny Zabaleta, Elad Ziv, Laura Fejerman. Cancer health disparities in racial/ethnic minorities in the United States. British Journal of Cancer 2021; 124(2): 315 doi: 10.1038/s41416-020-01038-6
82
Karen Hye-cheon Kim Yeary, Amanda J. Quisenberry, Marissa G. Hall, Han Yu, Whitney Ann E. Henry, Elisa Marie Rodriguez, Jamie M. Zoellner. Sweet Beverages and Cancer: A Scoping Review of Quantitative Studies. Cancer Prevention Research 2022; 15(6): 377 doi: 10.1158/1940-6207.CAPR-21-0507
83
Steffen Landerer, Sandra Kalthoff, Stefan Paulusch, Christian P. Strassburg. A Gilbert syndrome-associated haplotype protects against fatty liver disease in humanized transgenic mice. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-65481-4
84
Timothy M.E. Davis, Kirsten E. Peters, S. A. Paul Chubb, Leon A. Adams, Gary P. Jeffrey, Wendy A. Davis. Changes in the Epidemiology of Hepatobiliary Disease Complicating Type 2 Diabetes over 25 Years: The Fremantle Diabetes Study. Journal of Clinical Medicine 2020; 9(11): 3409 doi: 10.3390/jcm9113409
85
Khalid Alswat, Faisal M Sanai, Waleed Al-hamoudi, Mona Ismail, Yaser Dahlan, Hamdan Saleh AlGhamdi, Ibrahim Altraif, Abduljaleel Alalwan, Mohamed MA Babatin, Saleh A Alqahtani. Clinical and Metabolic Characteristics of Non-Alcoholic Fatty Liver Disease Patients in Saudi Arabia: Data from the Systematic Observatory Liver Disease (SOLID) Registry. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021; : 1167 doi: 10.2147/DMSO.S300051
86
Dongmei Zou, Liang Liu, Yinzhen Zeng, Huanhuan Wang, Dongling Dai, Mingguo Xu. LncRNA MEG3 up-regulates SIRT6 by ubiquitinating EZH2 and alleviates nonalcoholic fatty liver disease. Cell Death Discovery 2022; 8(1) doi: 10.1038/s41420-022-00889-7
87
Cheng Fang, Paul S. Sidhu. Ultrasound-based liver elastography: current results and future perspectives. Abdominal Radiology 2020; 45(11): 3463 doi: 10.1007/s00261-020-02717-x
88
Yu-Cheng Lin, Chi-Chien Wu, Yen-Hsuan Ni. New Perspectives on Genetic Prediction for Pediatric Metabolic Associated Fatty Liver Disease. Frontiers in Pediatrics 2020; 8 doi: 10.3389/fped.2020.603654
89
David L. Fisher , Stephen Malnick. Liver and COVID-19 - A Review and Clinical Approach. Coronaviruses 2022; 3(1) doi: 10.2174/2666796702666211005142343
90
Minjie Lin, Jungke Long, Wenbo Li, Chenxuan Yang, Patricia Loughran, Robert O’Doherty, Timothy R. Billiar, Meihong Deng, Melanie J. Scott. Hepatocyte high-mobility group box 1 protects against steatosis and cellular stress during high fat diet feeding. Molecular Medicine 2020; 26(1) doi: 10.1186/s10020-020-00227-6
91
Stefan Chiriac, Carol Stanciu, Irina Girleanu, Camelia Cojocariu, Catalin Sfarti, Ana-Maria Singeap, Tudor Cuciureanu, Laura Huiban, Cristina Maria Muzica, Sebastian Zenovia, Robert Nastasa, Anca Trifan, Branka Filipović. Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases: The Heart of the Matter. Canadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/6696857
92
Samar H. Gerges, Sara A. Wahdan, Doaa A. Elsherbiny, Ebtehal El-Demerdash. Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventions. Life Sciences 2021; 271: 119220 doi: 10.1016/j.lfs.2021.119220
93
Antonio Gnoni, Benedetta Di Chiara Stanca, Laura Giannotti, Gabriele Vincenzo Gnoni, Luisa Siculella, Fabrizio Damiano. Quercetin Reduces Lipid Accumulation in a Cell Model of NAFLD by Inhibiting De Novo Fatty Acid Synthesis through the Acetyl-CoA Carboxylase 1/AMPK/PP2A Axis. International Journal of Molecular Sciences 2022; 23(3): 1044 doi: 10.3390/ijms23031044
94
Qiaoling Wang, Binxia Chang, Xiaoyan Li, Zhengsheng Zou. Role of ALDH2 in Hepatic Disorders: Gene Polymorphism and Disease Pathogenesis. Journal of Clinical and Translational Hepatology 2021; 0(000): 1 doi: 10.14218/JCTH.2020.00104
95
Amreen Dinani, Norman Sussman, Mazen Noureddin, Michael Fuchs, George Therapondos, Nigel Girgrah, Viviana Figueroa Diaz, Parvez Mantry, Mary Rinella, Amon Asgharpour, Douglas Dieterich. An algorithm for the management of non-alcoholic fatty liver disease in primary care. Gastroenterology & Hepatology: Open Access 2021; 12(4): 114 doi: 10.15406/ghoa.2021.12.00469
96
Nina L. Gluchowski, Katlyn R. Gabriel, Chandramohan Chitraju, Roderick T. Bronson, Niklas Mejhert, Sebastian Boland, Kun Wang, Zon Weng Lai, Robert V. Farese, Tobias C. Walther. Hepatocyte Deletion of Triglyceride‐Synthesis Enzyme Acyl CoA: Diacylglycerol Acyltransferase 2 Reduces Steatosis Without Increasing Inflammation or Fibrosis in Mice. Hepatology 2019; 70(6): 1972 doi: 10.1002/hep.30765
97
Dandan Song, Chengqian Li, Zhongchao Wang, Yuhang Zhao, Baoming Shen, Wenjuan Zhao. Association of non‐alcoholic fatty liver disease with diabetic retinopathy in type 2 diabetic patients: A meta‐analysis of observational studies. Journal of Diabetes Investigation 2021; 12(8): 1471 doi: 10.1111/jdi.13489
98
Meng Zhang, Li Li, Jing Chen, Bei Li, Yutao Zhan, Chuan Zhang. Presence of diabetic retinopathy is lower in type 2 diabetic patients with non-alcoholic fatty liver disease. Medicine 2019; 98(18): e15362 doi: 10.1097/MD.0000000000015362
99
Liu Li, Li Yang, Feng Yang, Xin-lan Zhao, Shengjiang Xue, Fang-hua Gong. Ginkgo biloba Extract 50 (GBE50) Ameliorates Insulin Resistance, Hepatic Steatosis and Liver Injury in High Fat Diet-Fed Mice. Journal of Inflammation Research 2021; : 1959 doi: 10.2147/JIR.S302934
100
Maria Styliani Kalogirou, Olga Giouleme. Growing challenge of post-liver transplantation non-alcoholic fatty liver disease. World Journal of Transplantation 2022; 12(9): 281-287 doi: 10.5500/wjt.v12.i9.281
101
Mohammad Alizadeh, Mohammadreza Mohammad Hosseiniazar, Farkhondeh Alami, Somayyeh Bararnia Adabi. The effects of meal patterns on liver steatosis, fibrosis, and biochemical factors in patients with nonalcoholic fatty liver disease: a randomized controlled clinical trial. Journal of Diabetes & Metabolic Disorders 2024;  doi: 10.1007/s40200-023-01375-2
102
Leslimar Rios-Colon, Elena Arthur, Suryakant Niture, Qi Qi, John T. Moore, Deepak Kumar. The Role of Exosomes in the Crosstalk between Adipocytes and Liver Cancer Cells. Cells 2020; 9(9): 1988 doi: 10.3390/cells9091988
103
Andrew Ndakotsu, Govinathan Vivekanandan. The Role of Thiazolidinediones in the Amelioration of Nonalcoholic Fatty Liver Disease: A Systematic Review. Cureus 2022;  doi: 10.7759/cureus.25380
104
Tzu-chia Kuo, Yang-bor Lu, Chieh-lun Yang, Bin Wang, Lin-xin Chen, Ching-ping Su. Association of insulin resistance indicators with hepatic steatosis and fibrosis in patients with metabolic syndrome. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-023-03095-6
105
Aparamita Pandey, Prachi Dabhade, Anand Kumarasamy. Inflammatory Effects of Subacute Exposure of Roundup in Rat Liver and Adipose Tissue. Dose-Response 2019; 17(2): 155932581984338 doi: 10.1177/1559325819843380
106
A. Tvarijonaviciute, R. Barić-Rafaj, A. Horvatic, A. Muñoz-Prieto, N. Guillemin, E. Lamy, A. Tumpa, J.J. Ceron, S. Martinez-Subiela, V. Mrljak. Identification of changes in serum analytes and possible metabolic pathways associated with canine obesity-related metabolic dysfunction. The Veterinary Journal 2019; 244: 51 doi: 10.1016/j.tvjl.2018.12.006
107
Shahinul Alam, Shah Mohammad Fahim. Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease. World Journal of Hepatology 2021; 13(10): 1203-1207 doi: 10.4254/wjh.v13.i10.1203
108
Ming-Hui Yang, Wei-You Li, Ching-Fen Wu, Yi-Ching Lee, Allan Yi-Nan Chen, Yu-Chang Tyan, Yi-Ming Arthur Chen. Reversal of High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease by Metformin Combined with PGG, an Inducer of Glycine N-Methyltransferase. International Journal of Molecular Sciences 2022; 23(17): 10072 doi: 10.3390/ijms231710072
109
Yvonne Huber, Jörn M Schattenberg. Prävention gastroenterologischer Tumorerkrankungen. 2020; : 173 doi: 10.1007/978-3-662-58879-6_10
110
Evan E. Lebovitz, Anh Vinh T. Nguyen, Tetsuro Sakai. Economic considerations in abdominal transplantation. Best Practice & Research Clinical Anaesthesiology 2020; 34(1): 15 doi: 10.1016/j.bpa.2020.01.002
111
Yi-Jie Li, Brittney O Baumert, Nikos Stratakis, Jesse A Goodrich, Hao-Tian Wu, Jing-Xuan He, Yin-Qi Zhao, Max T Aung, Hong-Xu Wang, Sandrah P Eckel, Douglas I Walker, Damaskini Valvi, Michele A La Merrill, Justin R Ryder, Thomas H Inge, Todd Jenkins, Stephanie Sisley, Rohit Kohli, Stavra A Xanthakos, Andrea A Baccarelli, Rob McConnell, David V Conti, Lida Chatzi. Circulating microRNA expression and nonalcoholic fatty liver disease in adolescents with severe obesity. World Journal of Gastroenterology 2024; 30(4): 332-345 doi: 10.3748/wjg.v30.i4.332
112
Ziyi Li, Na Yang, Liyun He, Jialu Wang, Fan Ping, Wei Li, Lingling Xu, Huabing Zhang, Yuxiu Li. Estimates and trends of the global burden of NASH-related liver cancer attributable to high fasting plasma glucose in 1990–2019: analysis of data from the 2019 Global Burden of Disease Study. Diabetology & Metabolic Syndrome 2023; 15(1) doi: 10.1186/s13098-022-00976-w
113
Acharya Balkrishna, Vivek Gohel, Rani Singh, Monali Joshi, Yash Varshney, Jyotish Srivastava, Kunal Bhattacharya, Anurag Varshney. Tri-Herbal Medicine Divya Sarva-Kalp-Kwath (Livogrit) Regulates Fatty Acid-Induced Steatosis in Human HepG2 Cells through Inhibition of Intracellular Triglycerides and Extracellular Glycerol Levels. Molecules 2020; 25(20): 4849 doi: 10.3390/molecules25204849
114
Jagpreet Chhatwal, Ozden O. Dalgic, Wanyi Chen, Sumeyye Samur, Emily D. Bethea, Jade Xiao, Chin Hur, Kathleen E. Corey, Rohit Loomba. Analysis of a Simulation Model to Estimate Long-term Outcomes in Patients with Nonalcoholic Fatty Liver Disease. JAMA Network Open 2022; 5(9): e2230426 doi: 10.1001/jamanetworkopen.2022.30426
115
Mayumi Higashi, Masahiro Tanabe, Masatoshi Yamane, Mahesh B. Keerthivasan, Hiroshi Imai, Teppei Yonezawa, Michihiro Nakamura, Katsuyoshi Ito. Impact of fat on the apparent T1 value of the liver: assessment by water-only derived T1 mapping. European Radiology 2023; 33(10): 6844 doi: 10.1007/s00330-023-10052-0
116
Faisal M. Sanai, Abdullah Al Khathlan, Ahmad Al Fadhli, Ahmad S. Jazzar, Al Moutaz Hashim, Eid Mansour, Faisal Abaalkhail, Fuad Hasan, Hajer Al Mudaiheem, Huda Al Quraishi, Juliana Bottomley, Khalid A. Alswat, Mohammed Al Ghamdi, Mohamed Farghaly, Motaz Fathy, Nancy Awad, Omneya Mohamed, Sam Kozma, Waleed Al-Hamoudi, Ahmed Al-jedai. Clinical and economic burden of nonalcoholic steatohepatitis in Saudi Arabia, United Arab Emirates and Kuwait. Hepatology International 2021; 15(4): 912 doi: 10.1007/s12072-021-10182-x
117
Amanda Chaney. Obesity and Nonalcoholic Fatty Liver Disease. Nursing Clinics of North America 2021; 56(4): 543 doi: 10.1016/j.cnur.2021.07.009
118
Shailja C Shah, Xiangzhu Zhu, Qi Dai, Richard M Peek, Martha J Shrubsole. Magnesium intake is associated with a reduced risk of incident liver cancer, based on an analysis of the NIH-American Association of Retired Persons (NIH-AARP) Diet and Health Study prospective cohort. The American Journal of Clinical Nutrition 2021; 113(3): 630 doi: 10.1093/ajcn/nqaa326
119
Amélio F. Godoy-Matos, Wellington S. Silva Júnior, Cynthia M. Valerio. NAFLD as a continuum: from obesity to metabolic syndrome and diabetes. Diabetology & Metabolic Syndrome 2020; 12(1) doi: 10.1186/s13098-020-00570-y
120
Roberta Catania, Leo Jia, Maryam Haghshomar, Frank H. Miller, Amir A. Borhani. Detection of moderate hepatic steatosis on contrast-enhanced dual-source dual-energy CT: Role and accuracy of virtual non-contrast CT. European Journal of Radiology 2024; 172: 111328 doi: 10.1016/j.ejrad.2024.111328
121
Rohit Loomba, Robert Wong, Jeremy Fraysse, Sanatan Shreay, Suying Li, Stephen Harrison, Stuart C. Gordon. Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data. Alimentary Pharmacology & Therapeutics 2020; 51(11): 1149 doi: 10.1111/apt.15679
122
Tamoore Arshad, Pegah Golabi, James Paik, Alita Mishra, Zobair M. Younossi. Prevalence of Nonalcoholic Fatty Liver Disease in the Female Population. Hepatology Communications 2019; 3(1): 74 doi: 10.1002/hep4.1285
123
Luis E. Simental-Mendía, Claudia I. Gamboa-Gómez, Fernando Guerrero-Romero, Mario Simental-Mendía, Adriana Sánchez-García, Mariana Rodríguez-Ramírez. Pharmacological Properties of Plant-Derived Natural Products and Implications for Human Health. Advances in Experimental Medicine and Biology 2021; 1308: 257 doi: 10.1007/978-3-030-64872-5_18
124
Maobin Kuang, Song Lu, Qiyang Xie, Nan Peng, Shiming He, Changhui Yu, Jiajun Qiu, Guotai Sheng, Yang Zou. Abdominal obesity phenotypes are associated with the risk of developing non-alcoholic fatty liver disease: insights from the general population. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02393-9
125
Gaurav Gupta, Ridhima Wadhwa, Parijat Pandey, Sachin Kumar Singh, Monica Gulati, Saurabh Sajita, Meenu Mehta, Avinash Kumar Singh, Harish Dureja, Trudi Collet, Kavita Pabreja, Dinesh Kumar Chellappan, Kamal Dua. Pathophysiology of Obesity-Induced Health Complications. 2020; : 81 doi: 10.1007/978-3-030-35358-2_5
126
Hongwei Yi, Deyi Xu, Xudong Wu, Fang Xu, Lin Lin, Huiping Zhou. Isosteviol Protects Free Fatty Acid- and High Fat Diet-Induced Hepatic InjuryviaModulating PKC-β/p66Shc/ROS and Endoplasmic Reticulum Stress Pathways. Antioxidants & Redox Signaling 2019; 30(17): 1949 doi: 10.1089/ars.2018.7521
127
Satsuki Sato, Yohei Kamata, Takaomi Kessoku, Tomoko Shimizu, Takashi Kobayashi, Takeo Kurihashi, Shogo Takashiba, Kazu Hatanaka, Nobushiro Hamada, Toshiro Kodama, Takuma Higurashi, Masataka Taguri, Masato Yoneda, Haruki Usuda, Koichiro Wada, Atsushi Nakajima, Toshiya Morozumi, Masato Minabe. A cross-sectional study assessing the relationship between non-alcoholic fatty liver disease and periodontal disease. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-17917-2
128
静 雷. Effect Analysis of QCT in the Diagnosis of Fatty Liver in Perimenopausal Women. Advances in Clinical Medicine 2024; 14(01): 979 doi: 10.12677/ACM.2024.141140
129
Alexander L. Ticho, Pooja Malhotra, Pradeep K. Dudeja, Ravinder K. Gill, Waddah A. Alrefai. Comprehensive Physiology. 2019; : 21 doi: 10.1002/cphy.c190007
130
Winston Hernández-Ceballos, Jacqueline Cordova-Gallardo, Nahum Mendez-Sanchez. Gut Microbiota in Metabolic-associated Fatty Liver Disease and in Other Chronic Metabolic Diseases. Journal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2020.00131
131
Saverio Nucera, Rosa Maria Bulotta, Stefano Ruga, Rosamaria Caminiti, Maria Serra, Roberto Bava, Fabio Castagna, Carmine Lupia, Mariangela Marrelli, Filomena Conforti, Giancarlo Statti, Vincenzo Mollace, Ernesto Palma. Natural Products for the Treatment of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review. Scientia Pharmaceutica 2023; 91(4): 53 doi: 10.3390/scipharm91040053
132
Elena S. George, Surbhi Sood, Nicole Kiss, Robin M. Daly, Amanda J. Nicoll, Stuart K. Roberts, Brenton J. Baguley. The Evidence Surrounding Non-Alcoholic Fatty Liver Disease in Individuals with Cancer: A Systematic Literature Review. Current Oncology 2022; 30(1): 48 doi: 10.3390/curroncol30010005
133
Francesco Andreozzi, Elettra Mancuso, Elisa Mazza, Gaia Chiara Mannino, Teresa Vanessa Fiorentino, Franco Arturi, Elena Succurro, Maria Perticone, Angela Sciacqua, Tiziana Montalcini, Arturo Pujia, Giorgio Sesti. One‐hour post‐load glucose levels are associated with hepatic steatosis assessed by transient elastography. Diabetes, Obesity and Metabolism 2024; 26(2): 682 doi: 10.1111/dom.15358
134
Hao Chiang, Hsu-Feng Lu, Jui-Chieh Chen, Yu-Hsin Chen, Hsi-Tai Sun, Hsiu-Chen Huang, Hsiao-Hsuan Tien, Cheng Huang, Fatima Martel. Adlay Seed (Coix lacryma-jobi L.) Extracts Exhibit a Prophylactic Effect on Diet-Induced Metabolic Dysfunction and Nonalcoholic Fatty Liver Disease in Mice. Evidence-Based Complementary and Alternative Medicine 2020; 2020: 1 doi: 10.1155/2020/9519625
135
K.C. van Son, L.C. te Nijenhuis-Noort, S.C. Boone, D.O. Mook-Kanamori, A.G. Holleboom, P.R. Roos, H.J. Lamb, G. Alblas, M.J. Coenraad, F.R. Rosendaal, R. de Mutsert, M.E. Tushuizen. Prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) in a middle-aged population with overweight and normal liver enzymes, and diagnostic accuracy of noninvasive proxies. Medicine 2024; 103(1): e34934 doi: 10.1097/MD.0000000000034934
136
Jing Xie, Yong Shao, Jin Liu, Meilan Cui, Xiuxiao Xiao, Jingbo Gong, Binghua Xue, Qunwei Zhang, Xianwen Hu, Haifeng Duan. K27Q/K29Q mutations in sphingosine kinase 1 attenuate high-fat diet induced obesity and altered glucose homeostasis in mice. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-77096-w
137
Kaliyaperumal Kalaiyarasi, Acharyya Sanchalika, Low Hsien Min, Yap Wei Ming, Shelat Vishalkumar, Yew Kuo Chao, Low Jee Keem, Junnarkar Sameer, Huey Cheong Wei Terence, Tan Yen Ping. Transient Elastography Is the Best-Performing Non-Invasive Test of Liver Fibrosis in Obese Asian Patients with Non-Alcoholic Fatty Liver Disease: A Pilot, Cross-Sectional Study. Medicina 2024; 60(1): 169 doi: 10.3390/medicina60010169
138
Maryam Chegeni, Sairan Nili, Mehdi Darabi, Elham Gheysvandi, Razieh Zahedi, Elham Sharifian, HamidReza Shoraka, Mohammad Rostamkhani, LeiliAbedi Gheshlaghi. Prevalence of non-alcoholic fatty liver and its related factors in Iran: Systematic review and meta-analysis. Journal of Education and Health Promotion 2023; 12(1): 356 doi: 10.4103/jehp.jehp_1056_22
139
Bevin E. Blake, Colette N. Miller, Helen Nguyen, Vesna A. Chappell, Trina P. Phan, Dhiral P. Phadke, Michele R. Balik-Meisner, Deepak Mav, Ruchir R. Shah, Suzanne E. Fenton. Transcriptional pathways linked to fetal and maternal hepatic dysfunction caused by gestational exposure to perfluorooctanoic acid (PFOA) or hexafluoropropylene oxide-dimer acid (HFPO-DA or GenX) in CD-1 mice. Ecotoxicology and Environmental Safety 2022; 248: 114314 doi: 10.1016/j.ecoenv.2022.114314
140
David Haldrup, Chunshan Wei, Peter Holland-Fischer, Kurt Kristensen, Søren Rittig, Aksel Lange, Arne Hørlyck, Jan Solvig, Henning Grønbæk, Niels H. Birkebæk, Jan Frystyk. Effects of lifestyle intervention on IGF-1, IGFBP-3, and insulin resistance in children with obesity with or without metabolic-associated fatty liver disease. European Journal of Pediatrics 2022; 182(2): 855 doi: 10.1007/s00431-022-04731-1
141
Yii-Shiuan Lee, Shih-Hsi Song, Tzee-Chung Wu, Shang-Liang Wu, Ching-Feng Huang. Correlation of hepatic transient elastography measurements and abdominal adiposity in children: A cross-sectional study. Pediatrics & Neonatology 2023; 64(6): 631 doi: 10.1016/j.pedneo.2022.12.018
142
Si-Qin Long, Xiu-Feng Yu, Yu-Li Ge, Lu-Xiang Liu. Ginkgolide B ameliorates high-fat diet-induced hepatic steatosis and inflammation in mice. World Chinese Journal of Digestology 2020; 28(13): 519 doi: 10.11569/wcjd.v28.i13.519
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
143
Yang Zou, Ling Zhong, Chong Hu, Mingchun Zhong, Nan Peng, Guotai Sheng. LDL/HDL cholesterol ratio is associated with new-onset NAFLD in Chinese non-obese people with normal lipids: a 5-year longitudinal cohort study. Lipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01457-1
144
Gavin Low, Craig Ferguson, Stephanie Locas, Wendy Tu, Florin Manolea, Medica Sam, Mitchell P. Wilson. Multiparametric MR assessment of liver fat, iron, and fibrosis: a concise overview of the liver “Triple Screen”. Abdominal Radiology 2023; 48(6): 2060 doi: 10.1007/s00261-023-03887-0
145
Naoki Tanaka, Takefumi Kimura, Naoyuki Fujimori, Tadanobu Nagaya, Michiharu Komatsu, Eiji Tanaka. Current status, problems, and perspectives of non-alcoholic fatty liver disease research. World Journal of Gastroenterology 2019; 25(2): 163-177 doi: 10.3748/wjg.v25.i2.163
146
Claudia Luckert, Albert Braeuning, Georges de Sousa, Sigrid Durinck, Efrosini S. Katsanou, Parthena Konstantinidou, Kyriaki Machera, Emanuela S. Milani, Ad A. C. M. Peijnenburg, Roger Rahmani, Andreja Rajkovic, Deborah Rijkers, Anastasia Spyropoulou, Marianna Stamou, Geert Stoopen, Shana Sturla, Bernd Wollscheid, Nathalie Zucchini-Pascal, Alfonso Lampen. Adverse Outcome Pathway-Driven Analysis of Liver Steatosis in Vitro: A Case Study with Cyproconazole. Chemical Research in Toxicology 2018; 31(8): 784 doi: 10.1021/acs.chemrestox.8b00112
147
Ioan Sporea, Ruxandra Mare, Alina Popescu, Silviu Nistorescu, Victor Baldea, Roxana Sirli, Adina Braha, Alexandra Sima, Romulus Timar, Raluca Lupusoru. Screening for Liver Fibrosis and Steatosis in a Large Cohort of Patients with Type 2 Diabetes Using Vibration Controlled Transient Elastography and Controlled Attenuation Parameter in a Single-Center Real-Life Experience. Journal of Clinical Medicine 2020; 9(4): 1032 doi: 10.3390/jcm9041032
148
Manca Povsic, Louisa Oliver, Neha Raju Jiandani, Richard Perry, Juliana Bottomley. A structured literature review of interventions used in the management of nonalcoholic steatohepatitis (NASH). Pharmacology Research & Perspectives 2019; 7(3) doi: 10.1002/prp2.485
149
Thomas Schreiter, Robert K. Gieseler, Ramiro Vílchez-Vargas, Ruy Jauregui, Jan-Peter Sowa, Susanne Klein-Scory, Ruth Broering, Roland S. Croner, Jürgen W. Treckmann, Alexander Link, Ali Canbay. Transcriptome-Wide Analysis of Human Liver Reveals Age-Related Differences in the Expression of Select Functional Gene Clusters and Evidence for a PPP1R10-Governed ‘Aging Cascade’. Pharmaceutics 2021; 13(12): 2009 doi: 10.3390/pharmaceutics13122009
150
Joseph Pierre Aboumsallem, Ilayaraja Muthuramu, Mudit Mishra, Bart De Geest. Cholesterol-Lowering Gene Therapy Prevents Heart Failure with Preserved Ejection Fraction in Obese Type 2 Diabetic Mice. International Journal of Molecular Sciences 2019; 20(9): 2222 doi: 10.3390/ijms20092222
151
Andrea Gonzalez, Camila Huerta-Salgado, Josué Orozco-Aguilar, Francisco Aguirre, Franco Tacchi, Felipe Simon, Claudio Cabello-Verrugio, Ana Cipak Gasparovic. Role of Oxidative Stress in Hepatic and Extrahepatic Dysfunctions during Nonalcoholic Fatty Liver Disease (NAFLD). Oxidative Medicine and Cellular Longevity 2020; 2020: 1 doi: 10.1155/2020/1617805
152
Jiang-Hua Zhou, Jing-Jing Cai, Zhi-Gang She, Hong-Liang Li. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice. World Journal of Gastroenterology 2019; 25(11): 1307-1326 doi: 10.3748/wjg.v25.i11.1307
153
Victoria L. Slaughter, John W. Rumsey, Rachel Boone, Duaa Malik, Yunqing Cai, Narasimhan Narasimhan Sriram, Christopher J. Long, Christopher W. McAleer, Stephen Lambert, Michael L. Shuler, J. J. Hickman. Validation of an adipose-liver human-on-a-chip model of NAFLD for preclinical therapeutic efficacy evaluation. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-92264-2
154
Laura Valenzuela-Vallejo, Despina Sanoudou, Christos S. Mantzoros. Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease. Journal of Personalized Medicine 2023; 13(5): 830 doi: 10.3390/jpm13050830
155
Ciniso Sylvester Shabangu, Jee-Fu Huang, Hui-Hua Hsiao, Ming-Lung Yu, Wan-Long Chuang, Shu-Chi Wang. Liquid Biopsy for the Diagnosis of Viral Hepatitis, Fatty Liver Steatosis, and Alcoholic Liver Diseases. International Journal of Molecular Sciences 2020; 21(10): 3732 doi: 10.3390/ijms21103732
156
Asim Kichloo, Shantanu Solanki, Khwaja F Haq, Dushyant Dahiya, Beth Bailey, Dhanshree Solanki, Jagmeet Singh, Michael Albosta, Farah Wani, Michael Aljadah, Harshil Shah, Hafiz Khan, Syed-Mohammed Jafri. Association of non-alcoholic fatty liver disease with gallstone disease in the United States hospitalized patient population. World Journal of Gastrointestinal Pathophysiology 2021; 12(2): 14-24 doi: 10.4291/wjgp.v12.i2.14
157
Gen Yamada, Yasuhiro Hagiwara, Takeshi Kimura, Yoshinori Takeuchi, Koji Oba, Katsunori Masuda, Yutaka Matsuyama. Impact of Body Weight Gain on the Incidence of Nonalcoholic Fatty Liver Disease in Nonobese Japanese Individuals. American Journal of Gastroenterology 2021; 116(4): 733 doi: 10.14309/ajg.0000000000001030
158
Hideki Fujii, Haruna Doi, Tetsuhisa Ko, Taito Fukuma, Toru Kadono, Kohei Asaeda, Reo Kobayashi, Takahiro Nakano, Toshifumi Doi, Yoshikazu Nakatsugawa, Shinya Yamada, Takeshi Nishimura, Naoya Tomatsuri, Hideki Sato, Yusuke Okuyama, Hiroyuki Kimura, Etsuko Kishimoto, Nami Nakabe, Takatomo Shima. Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01369-x
159
Scott A. Reisman, Deborah A. Ferguson, Chun‐Yue I. Lee, Joel W. Proksch. Omaveloxolone and TX63682 are hepatoprotective in the STAM mouse model of nonalcoholic steatohepatitis. Journal of Biochemical and Molecular Toxicology 2020; 34(9) doi: 10.1002/jbt.22526
160
Magdy El-Gohary, Mike Moore, Paul Roderick, Emily Watkins, Joanne Dash, Tina Reinson, Colin Newell, Miranda Kim, Beth Stuart, Taeko Becque, Nick Sheron, Isabelle Chemin. Local care and treatment of liver disease (LOCATE) – A cluster-randomized feasibility study to discover, assess and manage early liver disease in primary care. PLOS ONE 2018; 13(12): e0208798 doi: 10.1371/journal.pone.0208798
161
Nilay D. Solanki, Kirti Vadi, Sandip Patel. Alleviating effect of Ficus racemosa in high-fat-high-fructose diet-induced non-alcoholic fatty liver disease. Indian Journal of Physiology and Pharmacology 2021; 65: 12 doi: 10.25259/IJPP_406_2020
162
Sex different effect of antibiotic and probiotic treatment on intestinal microbiota composition in chemically induced liver injury rats. Genomics 2023; 115(4): 110647 doi: 10.1016/j.ygeno.2023.110647
163
Maria Martin-Grau, Vannina G Marrachelli, Daniel Monleon. Rodent models and metabolomics in non-alcoholic fatty liver disease: What can we learn?. World Journal of Hepatology 2022; 14(2): 304-318 doi: 10.4254/wjh.v14.i2.304
164
Celso Pereira Batista Sousa-Filho, Victoria Silva, Anaysa Paola Bolin, Andrea Livia Silva Rocha, Rosemari Otton. Green tea actions on miRNAs expression – An update. Chemico-Biological Interactions 2023; 378: 110465 doi: 10.1016/j.cbi.2023.110465
165
Andrea C. Postmus, Ines Sturmlechner, Johan W. Jonker, Jan M. van Deursen, Bart van de Sluis, Janine K. Kruit. Senescent cells in the development of cardiometabolic disease. Current Opinion in Lipidology 2019; 30(3): 177 doi: 10.1097/MOL.0000000000000602
166
Sangmin You, Ai-Min Cui, Syed F. Hashmi, Xinmu Zhang, Christina Nadolny, Yuan Chen, Qiwen Chen, Xin Bush, Zachary Hurd, Winifer Ali, Gang Qin, Ruitang Deng. Dysregulation of bile acids increases the risk for preterm birth in pregnant women. Nature Communications 2020; 11(1) doi: 10.1038/s41467-020-15923-4
167
Masashi Hirooka, Sadanobu Ogawa, Yohei Koizumi, Yuichi Yoshida, Tatsuya Goto, Satoshi Yasuda, Masahiro Yamahira, Tsutomu Tamai, Ryoko Kuromatsu, Toshihisa Matsuzaki, Tomoyuki Suehiro, Yoshihiro Kamada, Yoshio Sumida, Yoichi Hiasa, Hidenori Toyoda, Takashi Kumada. iATT liver fat quantification for steatosis grading by referring to MRI proton density fat fraction: a multicenter study. Journal of Gastroenterology 2024;  doi: 10.1007/s00535-024-02096-w
168
Keyang Xu, Xu Zhao, Xiaoqing Fu, Kechen Xu, Zhaoyi Li, Liangbin Miao, Yan Li, Zhaobin Cai, Liang Qiao, Jianfeng Bao. Gender effect of hyperuricemia on the development of nonalcoholic fatty liver disease (NAFLD): A clinical analysis and mechanistic study. Biomedicine & Pharmacotherapy 2019; 117: 109158 doi: 10.1016/j.biopha.2019.109158
169
Guo-heng Zhang, Tian-hao Yuan, Zhen-sheng Yue, Lin Wang, Guo-Rui Dou. The presence of diabetic retinopathy closely associated with the progression of non-alcoholic fatty liver disease: A meta-analysis of observational studies. Frontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.1019899
170
Guotai Sheng, Nan Peng, Chong Hu, Ling Zhong, Mingchun Zhong, Yang Zou. The albumin-to-alkaline phosphatase ratio as an independent predictor of future non-alcoholic fatty liver disease in a 5-year longitudinal cohort study of a non-obese Chinese population. Lipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01479-9
171
Reza Etminani, ZaharaAbdul Manaf, Suzana Shahar, Leila Azadbakht, Peyman Adibi. Predictors of nonalcoholic fatty liver disease among middle-aged Iranians. International Journal of Preventive Medicine 2020; 11(1): 113 doi: 10.4103/ijpvm.IJPVM_274_19
172
Alexa M. Giammarino, He Qiu, Kishen Bulsara, Sabrina Khan, Yu Jiang, Ben L. Da, David E. Bernstein, Sanjaya K. Satapathy. Community Socioeconomic Deprivation Predicts Nonalcoholic Steatohepatitis. Hepatology Communications 2022; 6(3): 550 doi: 10.1002/hep4.1831
173
Konstantinos Damiris, Zaid H Tafesh, Nikolaos Pyrsopoulos. Efficacy and safety of anti-hepatic fibrosis drugs. World Journal of Gastroenterology 2020; 26(41): 6304-6321 doi: 10.3748/wjg.v26.i41.6304
174
Kristin M Hirahatake, Richard S Bruno, Bradley W Bolling, Christopher Blesso, Lacy M Alexander, Sean H Adams. Dairy Foods and Dairy Fats: New Perspectives on Pathways Implicated in Cardiometabolic Health. Advances in Nutrition 2020; 11(2): 266 doi: 10.1093/advances/nmz105
175
RehabF Abdel-Rahman. Non-alcoholic fatty liver disease: Epidemiology, pathophysiology and an update on the therapeutic approaches. Asian Pacific Journal of Tropical Biomedicine 2022; 12(3): 99 doi: 10.4103/2221-1691.338919
176
Christian L. Horn, Anvi C. Ta, Nadege T. Gunn. Current and Emerging Treatments for Non-alcoholic Steatohepatitis. Current Hepatology Reports 2020; 19(4): 391 doi: 10.1007/s11901-020-00540-y
177
Agata Muzsik-Kazimierska, Artur Szwengiel, Grzegorz Nikrandt, Agata Chmurzynska. Lower plasma glutathione, choline, and betaine concentrations are associated with fatty liver in postmenopausal women. Nutrition Research 2022; 101: 23 doi: 10.1016/j.nutres.2022.02.004
178
Zobair M. Younossi, Maria Stepanova, Issah Younossi, Andrei Racila. Validation of Chronic Liver Disease Questionnaire for Nonalcoholic Steatohepatitis in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis. Clinical Gastroenterology and Hepatology 2019; 17(10): 2093 doi: 10.1016/j.cgh.2019.01.001
179
Caterina Formichi, Laura Nigi, Giuseppina Emanuela Grieco, Carla Maccora, Daniela Fignani, Noemi Brusco, Giada Licata, Guido Sebastiani, Francesco Dotta. Non-Coding RNAs: Novel Players in Insulin Resistance and Related Diseases. International Journal of Molecular Sciences 2021; 22(14): 7716 doi: 10.3390/ijms22147716
180
Xueyan Gu, Xiaocui Ma, Limin Mo, Qiyu Wang. The Role of Exercise Intensity on Fatty Liver in Rats. Chinese Journal of Physiology 2022; 65(6): 301 doi: 10.4103/0304-4920.365461
181
Imran Ali, Hasan M. Khan, Muhammad Naveed Akram, Yang-Fang Chen, Mujahid Mustaqeem, Tawfik A. Saleh, Muhammad Ahmad, Imran Sadiq, Nimra Lateef. Zn/Ba nanoparticles doping effect on surface interface, Morphology, and dielectric elucidation of spinel ferrites. Surfaces and Interfaces 2023; 38: 102862 doi: 10.1016/j.surfin.2023.102862
182
Sathiyamoorthy Selladurai, Abhilash Verma, Arun K. Thittai. Toward Quantitative and Operator-independent Quasi-static Ultrasound Elastography: An Ex Vivo Feasibility Study. Ultrasonic Imaging 2020; 42(4-5): 179 doi: 10.1177/0161734620921532
183
Erika R. Bjørnå, Martine T. Engelsen, Hashem B. El-Serag, Eivind Ness-Jensen. Prevalence and risk factors of nonalcoholic fatty liver disease in a general population, the HUNT study. Scandinavian Journal of Gastroenterology 2023; 58(5): 505 doi: 10.1080/00365521.2022.2139633
184
Ke Xu, Mingming Shi, Weiteng Zhang, Yiyi Shi, Qiantong Dong, Xian Shen, Xiaolei Chen, Ji Lin. Preoperative Fibrosis-4 (FIB-4) Evaluation May Be Helpful to Evaluate Prognosis of Gastric Cancer Patients Undergoing Operation: A Retrospective Study. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.655343
185
Navya Malladi, Md Jahangir Alam, Subir K. Maulik, Sanjay K. Banerjee. The role of platelets in non-alcoholic fatty liver disease: From pathophysiology to therapeutics. Prostaglandins & Other Lipid Mediators 2023; 169: 106766 doi: 10.1016/j.prostaglandins.2023.106766
186
Chiranjeevi Gadiparthi, Moshe Spatz, Simi Greenberg, Umair Iqbal, Sowjanya Kanna, Sanjaya K Satapathy, Arkady Broder, Aijaz Ahmed. NAFLD Epidemiology, Emerging Pharmacotherapy, Liver Transplantation Implications and the Trends in the United States. Journal of Clinical and Translational Hepatology 2020; 8(2): 215 doi: 10.14218/JCTH.2020.00014
187
Manuel Romero-Gomez, Nandita Kachru, Meritxell Ascanio Zamorano, Josep Darba, Sanatan Shreay. Disease severity predicts higher healthcare costs among hospitalized nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) patients in Spain. Medicine 2020; 99(50): e23506 doi: 10.1097/MD.0000000000023506
188
Emilio Balbuena, Junrui Cheng, Abdulkerim Eroglu. Carotenoids in orange carrots mitigate non-alcoholic fatty liver disease progression. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.987103
189
Kwazi Gabuza, Thendo I. Mabuda, Oelfah Patel, Noxolo Khuboni, Ruzayda van Aarde, Sylvia Riedel, Nonhlakanipho F. Sangweni, Shantal Windvogel, Rabia Johnson, Christo J. F. Muller, Andrea Mastinu. Afriplex GRTTM extract attenuates hepatic steatosis in an in vitro model of NAFLD. PLOS ONE 2024; 19(4): e0297572 doi: 10.1371/journal.pone.0297572
190
Gourdas Choudhuri, Saumin Shah, Anand Kulkarni, Nitin Jagtap, Pratyusha Gaonkar, Akshay Desai, Charles Adhav. Non-alcoholic Steatohepatitis in Asians: Current Perspectives and Future Directions. Cureus 2023;  doi: 10.7759/cureus.42852
191
Zaida Zakaria, Zaidatul Akmal Othman, Joseph Bagi Suleiman, Nur Asyilla Che Jalil, Wan Syaheedah Wan Ghazali, Victor Udo Nna, Mahaneem Mohamed. Hepatoprotective Effect of Bee Bread in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Rats: Impact on Oxidative Stress and Inflammation. Antioxidants 2021; 10(12): 2031 doi: 10.3390/antiox10122031
192
Pinar Yilmaz, Louise J. M. Alferink, Lotte G. M. Cremers, Sarwa D. Murad, Wiro J. Niessen, M. Arfan Ikram, Meike W. Vernooij. Subclinical liver traits are associated with structural and hemodynamic brain imaging markers. Liver International 2023; 43(6): 1256 doi: 10.1111/liv.15549
193
Pingping Yu, Huachao Yang, Xiaoya Qi, Ruixue Bai, Shouqin Zhang, Jianping Gong, Ying Mei, Peng Hu. Gender differences in the ideal cutoffs of visceral fat area for predicting MAFLD in China. Lipids in Health and Disease 2022; 21(1) doi: 10.1186/s12944-022-01763-2
194
Joana L. Fernandes, Fátima O. Martins, Elena Olea, Jesus Prieto-Lloret, Patrícia C. Braga, Joana F. Sacramento, Catarina O. Sequeira, Ana P. Negrinho, Sofia A. Pereira, Marco G. Alves, Asunción Rocher, Silvia V. Conde. Chronic Intermittent Hypoxia-Induced Dysmetabolism Is Associated with Hepatic Oxidative Stress, Mitochondrial Dysfunction and Inflammation. Antioxidants 2023; 12(11): 1910 doi: 10.3390/antiox12111910
195
Anchalia Chandrakumaran, Mohammad Shadab Siddiqui. Implications of Nonalcoholic Steatohepatitis as the Cause of End-Stage Liver Disease Before and After Liver Transplant. Gastroenterology Clinics of North America 2020; 49(1): 165 doi: 10.1016/j.gtc.2019.09.005
196
Jiahui Li, Xin Lu, Zheng Zhu, Kyle J. Kalutkiewicz, Taofic Mounajjed, Terry M. Therneau, Sudhakar K. Venkatesh, Yi Sui, Kevin J. Glaser, Safa Hoodeshenas, Armando Manduca, Vijay H. Shah, Richard L. Ehman, Alina M. Allen, Meng Yin. Head-to-head comparison of magnetic resonance elastography-based liver stiffness, fat fraction, and T1 relaxation time in identifying at-risk NASH. Hepatology 2023; 78(4): 1200 doi: 10.1097/HEP.0000000000000417
197
Галина Корнован , Володимир Синенко , Лариса Колотвіна , Яна Бажора , Дарʼя Лагода , Вероніка Назарян , Ганна Амірова , Олена Паслар . КОМОРБІДНА ПАТОЛОГІЯ ПЕЧІНКИ У ПАЦІЄНТІВ, ЯКІ ЖИВУТЬ З ОЖИРІННЯМ. Grail of Science 2022; (17): 419 doi: 10.36074/grail-of-science.22.07.2022.073
198
Xiaomin Hua, Heping Zhang, Wenru Yang, Guotao Liu, Suhua Zhang, Yingcui Wang. SFI, a sex hormone binding globulin based nomogram for predicting non-alcoholic fatty liver disease in the Chinese population. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1176019
199
Amedeo Lonardo, Stefano Ballestri, Alessandro Mantovani, Fabio Nascimbeni, Simonetta Lugari, Giovanni Targher. Pathogenesis of hypothyroidism-induced NAFLD: Evidence for a distinct disease entity?. Digestive and Liver Disease 2019; 51(4): 462 doi: 10.1016/j.dld.2018.12.014
200
Miaoting Yang, Zhijuan Chen, Shijian Xiang, Fan Xia, Waijiao Tang, Xiaorui Yao, Benjie Zhou. Hugan Qingzhi medication ameliorates free fatty acid-induced L02 hepatocyte endoplasmic reticulum stress by regulating the activation of PKC-δ. BMC Complementary Medicine and Therapies 2020; 20(1) doi: 10.1186/s12906-020-03164-3
201
Ji-Youn Kim, Yong-Moon Park, Gyu-Na Lee, Hyun Chul Song, Yu-Bae Ahn, Kyungdo Han, Seung-Hyun Ko, Houkai Li. Association between toothbrushing and non-alcoholic fatty liver disease. PLOS ONE 2021; 16(5): e0243686 doi: 10.1371/journal.pone.0243686
202
Chang-hua Zhang, Bu-gao Zhou, Jun-qing Sheng, Yang Chen, Ying-qian Cao, Chen Chen. Molecular mechanisms of hepatic insulin resistance in nonalcoholic fatty liver disease and potential treatment strategies. Pharmacological Research 2020; 159: 104984 doi: 10.1016/j.phrs.2020.104984
203
Esther Rey, Elvira del Pozo-Maroto, Patricia Marañón, Brittany Beeler, Yaiza García-García, Pedro Landete, Stephania C. Isaza, Ramón Farré, Carmelo García-Monzón, Isaac Almendros, Águeda González-Rodríguez. Intrahepatic Expression of Fatty Acid Translocase CD36 Is Increased in Obstructive Sleep Apnea. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00450
204
Dimitrios Tsilingiris, Evangelia Tzeravini, Chrysi Koliaki, Maria Dalamaga, Alexander Kokkinos. The Role of Mitochondrial Adaptation and Metabolic Flexibility in the Pathophysiology of Obesity and Insulin Resistance: an Updated Overview. Current Obesity Reports 2021; 10(3): 191 doi: 10.1007/s13679-021-00434-0
205
Rui Gao, Xiaobo Zhang, Zhen Zhou, Jiayi Sun, Xuehua Tang, Jialiang Li, Xin Zhou, Tao Shen, Zhaoqi Dong. Pharmacological Mechanism of Ganlu Powder in the Treatment of NASH Based on Network Pharmacology and Molecular Docking. Disease Markers 2022; 2022: 1 doi: 10.1155/2022/7251450
206
Marc Gurun, Paul Brennan, Sava Handjiev, Aseil Khatib, Damien Leith, John F. Dillon, Christopher J. Byrne, Anna Di Sessa. Increased risk of chronic kidney disease and mortality in a cohort of people diagnosed with metabolic dysfunction associated steatotic liver disease with hepatic fibrosis. PLOS ONE 2024; 19(4): e0299507 doi: 10.1371/journal.pone.0299507
207
Mi-Bo Kim, Tho X. Pham, Molly vanLuling, Victoria Kostour, Hyunju Kang, Olivia Corvino, Hyungryun Jang, William Odell, Minkyung Bae, Young-Ki Park, Ji-Young Lee. Nicotinamide riboside supplementation exerts an anti–obesity effect and prevents inflammation and fibrosis in white adipose tissue of female diet-induced obesity mice. The Journal of Nutritional Biochemistry 2022; 107: 109058 doi: 10.1016/j.jnutbio.2022.109058
208
Graciela K. Krolow, Eduardo Garcia, Fabiola Schoor, Fernanda B.S. Araujo, Gabriela P. Coral. Obstructive sleep apnea and severity of nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 2021; 33(8): 1104 doi: 10.1097/MEG.0000000000001920
209
Maria Wallert, Lisa Börmel, Stefan Lorkowski. Inflammatory Diseases and Vitamin E—What Do We Know and Where Do We Go?. Molecular Nutrition & Food Research 2021; 65(1) doi: 10.1002/mnfr.202000097
210
Ioan Sporea, Raluca Lupușoru, Roxana Șirli. Elastography - Applications in Clinical Medicine. 2022;  doi: 10.5772/intechopen.102363
211
Neil R. Chappell, Beth Zhou, Pardis Hosseinzadeh, Amy Schutt, William E. Gibbons, Chellakkan S. Blesson. Hyperandrogenemia alters mitochondrial structure and function in the oocytes of obese mouse with polycystic ovary syndrome. F&S Science 2021; 2(1): 101 doi: 10.1016/j.xfss.2020.12.001
212
Jing Guo, Ingolf Sack, Stephan Rodrigo Marticorena Garcia. Liver Elastography. 2020; : 69 doi: 10.1007/978-3-030-40542-7_6
213
Faridoddin Mirshahi, Hussein F. Aqbi, Madison Isbell, Saeed H. Manjili, Chunqing Guo, Mulugeta Saneshaw, Dipankar Bandyopadhyay, Mikhail Dozmorov, Archit Khosla, Katy Wack, Oscar M. Carrasco-Zevallos, Michael O. Idowu, Xiang-Yang Wang, Arun J. Sanyal, Masoud H. Manjili. Distinct hepatic immunological patterns are associated with the progression or inhibition of hepatocellular carcinoma. Cell Reports 2022; 38(9): 110454 doi: 10.1016/j.celrep.2022.110454
214
Emilio Molina‐Molina, Guilherme Eustaquio. Furtado, John G. Jones, Piero Portincasa, Ana Vieira‐Pedrosa, Ana Maria Teixeira, Marcelo Paes Barros, André Luís Lacerda Bachi, Vilma A. Sardão. The advantages of physical exercise as a preventive strategy against NAFLD in postmenopausal women. European Journal of Clinical Investigation 2022; 52(3) doi: 10.1111/eci.13731
215
Laura Valenzuela-Vallejo, Christos S. Mantzoros. Time to transition from a negative nomenclature describing what NAFLD is not, to a novel, pathophysiology-based, umbrella classification of fatty liver disease (FLD). Metabolism 2022; 134: 155246 doi: 10.1016/j.metabol.2022.155246
216
Linda Henry, James Paik, Zobair M. Younossi. Review article: the epidemiologic burden of non‐alcoholic fatty liver disease across the world. Alimentary Pharmacology & Therapeutics 2022; 56(6): 942 doi: 10.1111/apt.17158
217
Hanieh Barghchi, Narges Milkarizi, Saba Belyani, Andisheh Norouzian Ostad, Vahid Reza Askari, Farnood Rajabzadeh, Ladan Goshayeshi, Seyede Yegane Ghelichi Kheyrabadi, Maryam Razavidarmian, Zahra Dehnavi, Seyyed Reza Sobhani, Mohsen Nematy. Pomegranate (Punica granatum L.) peel extract ameliorates metabolic syndrome risk factors in patients with non-alcoholic fatty liver disease: a randomized double-blind clinical trial. Nutrition Journal 2023; 22(1) doi: 10.1186/s12937-023-00869-2
218
Alexandra Lasch, Philip Marx-Stoelting, Albert Braeuning, Dajana Lichtenstein. More than additive effects on liver triglyceride accumulation by combinations of steatotic and non-steatotic pesticides in HepaRG cells. Archives of Toxicology 2021; 95(4): 1397 doi: 10.1007/s00204-021-02997-2
219
Simin Fan, Zunming Zhou, Jintong Ye, Yanfang Li, Keer Huang, Xuehong Ke, Waseem Hassan. Integration of Lipidomics and Transcriptomics Reveals the Efficacy and Mechanism of Qige Decoction on NAFLD. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/9739032
220
Dongxu Wang, Bing He. Current Perspectives on Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2022; : 1281 doi: 10.2147/DMSO.S362424
221
Fatemeh Haidari, Abdollah Hojhabrimanesh, Bizhan Helli, Seyed-Saeed Seyedian, Kambiz Ahmadi-Angali, Behnaz Abiri. A hypocaloric high-protein diet supplemented with β-cryptoxanthin improves non-alcoholic fatty liver disease: a randomized controlled trial. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01502-w
222
Nirmalya Sinha, Saptarshi Mukhopadhyay, Manabendra Sau. Metabolic syndrome is not uncommon among lean non-alcoholic fatty liver disease patients as compared with those with obesity. Indian Journal of Gastroenterology 2020; 39(1): 75 doi: 10.1007/s12664-020-01020-3
223
Maxime Tremblay, Nicolas Perrot, Nooshin Ghodsian, Émilie Gobeil, Christian Couture, Patricia L Mitchell, Sébastien Thériault, Benoit J Arsenault. Circulating Galectin-3 Levels Are Not Associated With Nonalcoholic Fatty Liver Disease: A Mendelian Randomization Study. The Journal of Clinical Endocrinology & Metabolism 2021; 106(8): e3178 doi: 10.1210/clinem/dgab144
224
Yuting Ma, Chengxia Kan, Hongyan Qiu, Yongping Liu, Ningning Hou, Fang Han, Junfeng Shi, Xiaodong Sun. Transcriptomic Analysis Reveals the Protective Effects of Empagliflozin on Lipid Metabolism in Nonalcoholic Fatty Liver Disease. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.793586
225
Olfa Khalifa, Neyla S. AL-Akl, Khaoula Errafii, Abdelilah Arredouani. Exendin-4 alleviates steatosis in an in vitro cell model by lowering FABP1 and FOXA1 expression via the Wnt/-catenin signaling pathway. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-06143-5
226
Andrew Yang, Melinda Nguyen, Irene Ju, Anthony Brancatisano, Brendan Ryan, David van der Poorten. Utility of Fibroscan XL to assess the severity of non-alcoholic fatty liver disease in patients undergoing bariatric surgery. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-93294-6
227
Mohamed Elfaal, Alanna Supersad, Craig Ferguson, Stephanie Locas, Florin Manolea, Mitchell P Wilson, Medica Sam, Wendy Tu, Gavin Low. Two-point Dixon and six-point Dixon magnetic resonance techniques in the detection, quantification and grading of hepatic steatosis. World Journal of Radiology 2023; 15(10): 293-303 doi: 10.4329/wjr.v15.i10.293
228
Pichamol Jirapinyo, Thomas R. McCarty, Russell D. Dolan, Raj Shah, Christopher C. Thompson. Effect of Endoscopic Bariatric and Metabolic Therapies on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 2022; 20(3): 511 doi: 10.1016/j.cgh.2021.03.017
229
Seyed Mostafa Parizadeh, Seyed Alireza Parizadeh, Mohadese Alizade-Noghani, Reza Jafarzadeh-Esfehani, Maryam Ghandehari, Ali Mottaghi-Moghaddam, Fatemeh Goldani, Majid Khazaei, Majid Ghayour-Mobarhan, Gordon A. Ferns, Seyed Mahdi Hassanian, Amir Avan. Association between non-alcoholic fatty liver disease and colorectal cancer. Expert Review of Gastroenterology & Hepatology 2019; 13(7): 633 doi: 10.1080/17474124.2019.1617696
230
Seonghae Yoon, Heechan Lee, Sang‐Chun Ji, Seo Hyun Yoon, Joo‐Youn Cho, Jae‐Yong Chung. Pharmacokinetics and Pharmacodynamics of Ursodeoxycholic Acid in an Overweight Population With Abnormal Liver Function. Clinical Pharmacology in Drug Development 2021; 10(1): 68 doi: 10.1002/cpdd.790
231
Muhammad Sohaib Asghar, Maira Hassan, Uzma Rasheed, Syed Jawad Haider Kazmi, Noman A Khan, Faran Khalid, Ayesha Anum, Saira Anwar. Impact of Fasting Lipid Profile on Chronic Kidney Disease Patients Having Fatty Liver Disease. Cureus 2020;  doi: 10.7759/cureus.11146
232
Kiarash Riazi, Hassan Azhari, Jacob H Charette, Fox E Underwood, James A King, Elnaz Ehteshami Afshar, Mark G Swain, Stephen E Congly, Gilaad G Kaplan, Abdel-Aziz Shaheen. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology 2022; 7(9): 851 doi: 10.1016/S2468-1253(22)00165-0
233
Razk Abdalgwad, Mohammed F. Rafey, Siobhan Foy, Micheál Newell, Colin Davenport, Derek T. O'Keeffe, Francis M. Finucane. Long-Term Changes in Weight in Patients With Severe and Complicated Obesity After Completion of a Milk-Based Meal Replacement Programme. Frontiers in Nutrition 2020; 7 doi: 10.3389/fnut.2020.551068
234
Yicheng Jiang, Yu Wang, Shuai Chen, Zhixin Liu, Haojun Yang, Yuwen Jiao, Liming Tang, Guangtao Xu. Screening of Biomarkers in Liver Tissue after Bariatric Surgery Based on WGCNA and SVM-RFE Algorithms. Disease Markers 2023; 2023: 1 doi: 10.1155/2023/2970429
235
Thaddeus J. Maguire, Aditya Shreenivas, William S. Rilling. Image-Guided Interventions in Oncology. 2020; : 81 doi: 10.1007/978-3-030-48767-6_6
236
Eric J. Hyzny, Ernest G. Chan, Matthew Morrell, Takashi Harano, Pablo G. Sanchez. A review of liver dysfunction in the lung transplant patient. Clinical Transplantation 2021; 35(8) doi: 10.1111/ctr.14344
237
MERTK+/hi M2c Macrophages Induced by Baicalin Alleviate Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2021; 22(19): 10604 doi: 10.3390/ijms221910604
238
Kader Torbator, Stephanie Poo, Taif Al-Rubaye, Leah Mapara, Sungeeta Punjabi, Ali Al-Rubaye, Laith Alrubaiy. Whether Screening for Non-alcoholic Fatty Liver Disease in Patients With Psoriasis Is Necessary: A Pilot Quality Improvement Project. Cureus 2022;  doi: 10.7759/cureus.24714
239
Mohamed I. Elsaid, You Li, Carolyn Catalano, Carlos D. Minacapelli, Kapil Gupta, Vinod K. Rustgi. Healthcare Utilization and Cost Burden of Porphyria in Commercially Insured Adults in the United States. PharmacoEconomics - Open 2021; 5(1): 89 doi: 10.1007/s41669-020-00229-4
240
Faridoddin mirshahi, Hussein Aqbi, Madison Isbell, Saeed Manjili, Chunqing Guo, Mulugeta Saneshaw, Dipankar Bandyopadhyay, Mikhail Dozmorov, Archit Khosla, Katy Wack, Oscar Carrasco-Zevallos, Michael Idowu, Xiang-Yang Wang, Arun Sanyal, Masoud Manjili. Distinct Hepatic Immunological Patterns are Associated With the Progression or Inhibition of Hepatocellular Carcinoma. SSRN Electronic Journal 2021;  doi: 10.2139/ssrn.3927425
241
Hande Erman, Engin Beydogan, Seher Irem Cetin, Banu Boyuk. Endocan: A Biomarker for Hepatosteatosis in Patients with Metabolic Syndrome. Mediators of Inflammation 2020; 2020: 1 doi: 10.1155/2020/3534042
242
Lu Liu, Sen Sun, Xiaohua Li. A network pharmacology-based approach to explore the effect of dihydromyricetin on non-alcoholic fatty liver rats via regulating PPARG and CASP3. Molecular and Cellular Probes 2023; 71: 101926 doi: 10.1016/j.mcp.2023.101926
243
Hyunji Lee, Heejin Bae, Ja Kyung Yoon, June Park, Yong Eun Chung. Comparison of Volumetric Measurement Method With Region of Interest Drawing Method for Liver Fat Quantification. Investigative Magnetic Resonance Imaging 2024; 28(1): 27 doi: 10.13104/imri.2023.0020
244
Sarayu A. Pai, Renuka P. Munshi, Falguni H. Panchal, Ila-Shruti Gaur, Snehal N. Mestry, Malvika S. Gursahani, Archana R. Juvekar. Plumbagin reduces obesity and nonalcoholic fatty liver disease induced by fructose in rats through regulation of lipid metabolism, inflammation and oxidative stress. Biomedicine & Pharmacotherapy 2019; 111: 686 doi: 10.1016/j.biopha.2018.12.139
245
Chen Shen, Jin Hong Chen, Ha Ram Oh, Ji Hyun Park. Transcription factor SOX2 contributes to nonalcoholic fatty liver disease development by regulating the expression of the fatty acid transporter CD36. FEBS Letters 2021; 595(19): 2493 doi: 10.1002/1873-3468.14193
246
Yingfei Xi, Hongshan Li. Role of farnesoid X receptor in hepatic steatosis in nonalcoholic fatty liver disease. Biomedicine & Pharmacotherapy 2020; 121: 109609 doi: 10.1016/j.biopha.2019.109609
247
Yang Zou, Ling Zhong, Chong Hu, Guotai Sheng. Association between the alanine aminotransferase/aspartate aminotransferase ratio and new-onset non-alcoholic fatty liver disease in a nonobese Chinese population: a population-based longitudinal study. Lipids in Health and Disease 2020; 19(1) doi: 10.1186/s12944-020-01419-z
248
Amin Ullah, Ahmad Ud Din, Wen Ding, Zheng Shi, Sadaf Pervaz, Bairong Shen. A narrative review: CXC chemokines influence immune surveillance in obesity and obesity-related diseases: Type 2 diabetes and nonalcoholic fatty liver disease. Reviews in Endocrine and Metabolic Disorders 2023; 24(4): 611 doi: 10.1007/s11154-023-09800-w
249
Marleigh Hefner, Vineet Baliga, Kailinn Amphay, Daniela Ramos, Vijay Hegde. Cardiometabolic Modification of Amyloid Beta in Alzheimer’s Disease Pathology. Frontiers in Aging Neuroscience 2021; 13 doi: 10.3389/fnagi.2021.721858
250
Stuart C. Gordon, Jeremy Fraysse, Suying Li, A. Burak Ozbay, Robert J. Wong. Disease Severity Is Associated With Higher Healthcare Utilization in Nonalcoholic Steatohepatitis Medicare Patients. American Journal of Gastroenterology 2020; 115(4): 562 doi: 10.14309/ajg.0000000000000484
251
Tsung-Hsien Chou, Hsing-Jung Yeh, Chun-Chao Chang, Jui-Hsiang Tang, Wei-Yu Kao, I-Chia Su, Chien-Hung Li, Wei-Hao Chang, Chun-Kai Huang, Herdiantri Sufriyana, Emily Chia-Yu Su. Deep learning for abdominal ultrasound: A computer-aided diagnostic system for the severity of fatty liver. Journal of the Chinese Medical Association 2021; 84(9): 842 doi: 10.1097/JCMA.0000000000000585
252
Rajesh Krithika, Ramtej Jayaram Verma. Hypolipidemic and Hypoglycemic Effects of Hydroalcoholic Extract of Solanum nigrum Linn. in CCl4-induced Hepatotoxicity in Mice. Toxicology and Environmental Health Sciences 2018; 10(5): 268 doi: 10.1007/s13530-018-0375-z
253
Jacqueline Córdova-Gallardo, Andrew P. Keaveny, Xingshun Qi, Nahum Méndez-Sánchez. Metabolic associated fatty liver disease and acute-on-chronic liver failure: common themes for common problems. European Journal of Gastroenterology & Hepatology 2021; 33(1S): e84 doi: 10.1097/MEG.0000000000002335
254
Vahid Sheikhi, Zahra Heidari. Association of subclinical hypothyroidism with nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: A cross-sectional study. Advanced Biomedical Research 2022; 11(1): 124 doi: 10.4103/abr.abr_15_21
255
Jitka Starekova, Scott B. Reeder. Liver fat quantification: where do we stand?. Abdominal Radiology 2020; 45(11): 3386 doi: 10.1007/s00261-020-02783-1
256
Masafumi Kuzuya, Rong Qian Shi, Madoka Yanagawa, Kazuhisa Watanabe, Satoshi Samizo, Ryota Ando. Long‐lived Werner syndrome patient autopsy report: The presence of liver cirrhosis. Geriatrics & Gerontology International 2021; 21(5): 433 doi: 10.1111/ggi.14149
257
Jaskamal Padda, Khizer Khalid, Anwar Khedr, Fahriba Tasnim, Ola A Al-Ewaidat, Ayden Charlene Cooper, Gutteridge Jean-Charles. Non-Alcoholic Fatty Liver Disease and Its Association With Diabetes Mellitus. Cureus 2021;  doi: 10.7759/cureus.17321
258
M. A. Livzan, T. S. Krolevets, M. I. Syrovenko. Liver fibrosis in a comorbid patient with metabolicassociated (non-alcoholic) fatty liver disease (MAFLD-NAFLD) and cardiovascular disease. Experimental and Clinical Gastroenterology 2023; (4): 133 doi: 10.31146/1682-8658-ecg-212-4-133-139
259
Helena Julià, David Benaiges, Juan Pedro-Botet. Bariatric surgery and non-alcoholic fatty liver disease. Medicina Clínica (English Edition) 2022; 158(11): 550 doi: 10.1016/j.medcle.2022.05.009
260
Francesco Bifari, Roberto Manfrini, Michele Dei Cas, Cesare Berra, Matteo Siano, Massimo Zuin, Rita Paroni, Franco Folli. Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Pharmacological Research 2018; 137: 219 doi: 10.1016/j.phrs.2018.09.025
261
Annah P. Baykal, Elizabeth J. Parks, Robert Shamburek, Majid M. Syed-Abdul, Shaji Chacko, Elaine Cochran, Megan Startzell, Ahmed M. Gharib, Ronald Ouwerkerk, Khaled Z. Abd-Elmoniem, Peter J. Walter, Mary Walter, Ranganath Muniyappa, Stephanie T. Chung, Rebecca J. Brown. Leptin decreases de novo lipogenesis in patients with lipodystrophy. JCI Insight 2020; 5(14) doi: 10.1172/jci.insight.137180
262
Danny Orabi, Nathan A. Berger, J. Mark Brown. Abnormal Metabolism in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: Mechanistic Insights to Chemoprevention. Cancers 2021; 13(14): 3473 doi: 10.3390/cancers13143473
263
Yoon-a Hwang, Hye Won Lee, Sang Hoon Ahn, Eun Jig Lee, Cheol Ryong Ku, Seung Up Kim. Positive association between nonalcoholic fatty liver disease and growth hormone deficiency in patients with nonfunctioning pituitary adenoma. Frontiers in Endocrinology 2023; 13 doi: 10.3389/fendo.2022.1057769
264
Ioannis I. Moustakas, Angeliki Katsarou, Aigli-Ioanna Legaki, Iryna Pyrina, Konstantinos Ntostoglou, Alkistis-Maria Papatheodoridi, Bettina Gercken, Ioannis S. Pateras, Vassilis G. Gorgoulis, Michael Koutsilieris, Triantafyllos Chavakis, Antonios Chatzigeorgiou. Hepatic Senescence Accompanies the Development of NAFLD in Non-Aged Mice Independently of Obesity. International Journal of Molecular Sciences 2021; 22(7): 3446 doi: 10.3390/ijms22073446
265
Nirupama Esther Jerome, Nancy E. Edwards, Qinglan (Priscilla) Ding. Impact of Mediterranean Dietary Education on Symptoms for Adults at Risk for Nonalcoholic Fatty Liver Disease. Gastroenterology Nursing 2023; 46(5): 359 doi: 10.1097/SGA.0000000000000753
266
Amy W Rachfal, Struan FA Grant, Stanley S Schwartz. The Diabetes Syndrome – A Collection of Conditions with Common, Interrelated Pathophysiologic Mechanisms. International Journal of General Medicine 2021; : 923 doi: 10.2147/IJGM.S305156
267
Muhammad Usman, Nabiyah Bakhtawar. Vitamin E as an Adjuvant Treatment for Non-alcoholic Fatty Liver Disease in Adults: A Systematic Review of Randomized Controlled Trials . Cureus 2020;  doi: 10.7759/cureus.9018
268
Minjuan Ma, Rui Duan, Hong Zhong, Tingming Liang, Li Guo. The Crosstalk between Fat Homeostasis and Liver Regional Immunity in NAFLD. Journal of Immunology Research 2019; 2019: 1 doi: 10.1155/2019/3954890
269
Somaya Albhaisi, Arun J. Sanyal. Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date. Pharmaceutical Medicine 2019; 33(6): 451 doi: 10.1007/s40290-019-00305-z
270
Teresa Vanessa Fiorentino, Francesca De Vito, Evelina Suraci, Raffaella Marasco, Federica Catalano, Francesco Andreozzi, Marta Letizia Hribal, Francesco Luzza, Giorgio Sesti. Augmented duodenal levels of sodium/glucose co-transporter 1 are associated with higher risk of nonalcoholic fatty liver disease and noninvasive index of liver fibrosis. Diabetes Research and Clinical Practice 2022; 185: 109789 doi: 10.1016/j.diabres.2022.109789
271
Vincenzo Cuccurullo, Giuseppe Danilo Di Stasio, Giuseppe Mazzarella, Giuseppe Lucio Cascini. Microvascular Invasion in HCC: The Molecular Imaging Perspective. Contrast Media & Molecular Imaging 2018; 2018: 1 doi: 10.1155/2018/9487938
272
Hui Zhao, Xiang Gao, Zhizuo Liu, Lei Zhang, Xuan Fang, Jianping Sun, Zhaofeng Zhang, Yongye Sun. Sodium Alginate Prevents Non-Alcoholic Fatty Liver Disease by Modulating the Gut–Liver Axis in High-Fat Diet-Fed Rats. Nutrients 2022; 14(22): 4846 doi: 10.3390/nu14224846
273
Anna Radziejewska, Agata Muzsik, Fermín I. Milagro, J. Alfredo Martínez, Agata Chmurzynska. One-Carbon Metabolism and Nonalcoholic Fatty Liver Disease: The Crosstalk between Nutrients, Microbiota, and Genetics. Lifestyle Genomics 2020; 13(2): 53 doi: 10.1159/000504602
274
Lívia Pimentel de Sant'Ana, Dalila Juliana S. Ribeiro, Aline Maria Araújo Martins, Fábio Neves dos Santos, Rafael Corrêa, Raquel das Neves Almeida, Marcos Nogueira Eberlin, Corinne F. Maurice, Kelly Grace Magalhães. Absence of the Caspases 1/11 Modulates Liver Global Lipid Profile and Gut Microbiota in High-Fat-Diet-Induced Obese Mice. Frontiers in Immunology 2020; 10 doi: 10.3389/fimmu.2019.02926
275
Rongjia Qi, Rong Jiang, Hanxianzhi Xiao, Ziling Wang, Siyuan He, Lu Wang, Yaping Wang. Ginsenoside Rg1 protects against d-galactose induced fatty liver disease in a mouse model via FOXO1 transcriptional factor. Life Sciences 2020; 254: 117776 doi: 10.1016/j.lfs.2020.117776
276
Erlin Chen, Bin Zhou, Saiyan Bian, Wenkai Ni, Zhong Chen, Gagan Chhabra. The lncRNA B3GALT5-AS1 Functions as an HCC Suppressor by Regulating the miR-934/UFM1 Axis. Journal of Oncology 2021; 2021: 1 doi: 10.1155/2021/1776432
277
Han Zhang, Qinghui Niu, Kun Liang, Xuesen Li, Jing Jiang, Cheng Bian. Effect of LncPVT1/miR-20a-5p on Lipid Metabolism and Insulin Resistance in NAFLD. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021; : 4599 doi: 10.2147/DMSO.S338097
278
Tasur Kumar Seen, Muntazir Sayed, Muhammad Bilal, Jonathan Vincent Reyes, Priyanka Bhandari, Vennis Lourdusamy, Ahmed Al-khazraji, Umer Syed, Yasar Sattar, Raghav Bansal. Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosis. World Journal of Gastroenterology 2021; 27(23): 3238-3248 doi: 10.3748/wjg.v27.i23.3238
279
Mandour Omer Mandour, Mohammed El-Hassan, Rawan M Elkomi, Jude A Oben. Non-alcoholic fatty liver disease: Is surgery the best current option and can novel endoscopy play a role in the future?. World Journal of Hepatology 2022; 14(9): 1704-1717 doi: 10.4254/wjh.v14.i9.1704
280
Xian-ju Huang, Cai-jing He, Shuai Liang, Jing Wang, Jun Li, Guang-zhong Yang, Zhang Zhao. Veratrilla baillonii Franch Could Alleviate Lipid Accumulation in LO2 Cells by Regulating Oxidative, Inflammatory, and Lipid Metabolic Signaling Pathways. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.575772
281
Michael J. Trujillo, Johnson Chen, Jonathan M. Rubin, Jing Gao. Non-invasive imaging biomarkers to assess nonalcoholic fatty liver disease: A review. Clinical Imaging 2021; 78: 22 doi: 10.1016/j.clinimag.2021.02.039
282
FUJI YANG, YAN HUANG, YOUWEN TAN, YONGMIN YAN. Ubiquitin-like posttranslational modifications in NAFLD progression and treatment. BIOCELL 2022; 46(2): 389 doi: 10.32604/biocell.2021.015899
283
Alexandra Wuopio, Brett M. Baker, Benjamin Koethe, Martin D. Goodman, Reuben Shin, Nikolay Bugaev, Dmitry Nepomnayshy, Woon Cho Kim, Thomas Schnelldorfer. Can Surgeons Reliably Identify Non-cirrhotic Liver Disease During Laparoscopic Bariatric Surgery?. Obesity Surgery 2024; 34(3): 769 doi: 10.1007/s11695-024-07070-2
284
Naga Swetha Samji, Rajanshu Verma, Krishna Chaitanya Keri, Ashwani K. Singal, Aijaz Ahmed, Mary Rinella, David Bernstein, Manal F. Abdelmalek, Sanjaya K. Satapathy. Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges. Digestive Diseases and Sciences 2019; 64(12): 3413 doi: 10.1007/s10620-019-05716-1
285
Waqas B. Khalid, Xucai Chen, Kang Kim. Multifocus Thermal Strain Imaging Using a Curved Linear Array Transducer for Identification of Lipids in Deep Tissue. Ultrasound in Medicine & Biology 2021; 47(7): 1711 doi: 10.1016/j.ultrasmedbio.2021.03.005
286
Yujin Park, Deepthi Thadasina, Ifeoluwa Bolujo, Abdulkadir Isidan, Arthur A. Cross-Najafi, Kevin Lopez, Ping Li, Andrew M. Dahlem, Lindsey Kennedy, Keisaku Sato, Heather Francis, Gianfranco Alpini, Wenjun Zhang, Burcin Ekser. Three-Dimensional Organoids as a Model to Study Nonalcoholic Fatty Liver Disease. Seminars in Liver Disease 2022; 42(04): 423 doi: 10.1055/a-1934-5588
287
Hongkun Xue, Yu Wang, Hongwei Xiang, Qi Song, Guowei Zhang, Jianguo Wang, Shaoqin Ge, Rajeev K Singla. Exploring the Protective Effects and Mechanism of Huaji Jianpi Decoction against Nonalcoholic Fatty Liver Disease by Network Pharmacology and Experimental Validation. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/5440347
288
Yue Zhou, Yunzhi Ni, Zhihong Wang, Gerald J. Prud’homme, Qinghua Wang. Causal effects of non-alcoholic fatty liver disease on osteoporosis: a Mendelian randomization study. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1283739
289
Lauren A. Newman, Zivile Useckaite, Jillian Johnson, Michael J. Sorich, Ashley M. Hopkins, Andrew Rowland. Selective Isolation of Liver-Derived Extracellular Vesicles Redefines Performance of miRNA Biomarkers for Non-Alcoholic Fatty Liver Disease. Biomedicines 2022; 10(1): 195 doi: 10.3390/biomedicines10010195
290
Felipe David Mendonça Chaim, Lívia Bitencourt Pascoal, Fábio Henrique Mendonça Chaim, Bruna Biazon Palma, Tiago Andrade Damázio, Larissa Bastos Eloy da Costa, Rita Carvalho, Everton Cazzo, Martinho Antônio Gestic, Murillo Pimentel Utrini, Marciane Milanski, Elinton Adami Chaim, Raquel Franco Leal. Histological grading evaluation of non-alcoholic fatty liver disease after bariatric surgery: a retrospective and longitudinal observational cohort study. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-65556-2
291
Lijuan Li, Kun Hou, Mengya Yuan, Yan Zhang, Yang Zhang. Change lifestyle modification plan/transtheoretical model in non-alcoholic simple fatty liver disease: a pilot randomized study. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02506-4
292
Lauren S. Strathearn, Afanasii I. Stepanov, Joan Font-Burgada. Inflammation in Primary and Metastatic Liver Tumorigenesis–Under the Influence of Alcohol and High-Fat Diets. Nutrients 2020; 12(4): 933 doi: 10.3390/nu12040933
293
Yeonsoo Jang, Ji Yea Lee, Seung Up Kim, Beomkyung Kim. A qualitative study of self‐management experiences in people with non‐alcoholic fatty liver disease. Nursing Open 2021; 8(6): 3135 doi: 10.1002/nop2.1025
294
Hendrik Strebel, Bernhard Haller, Maximilian Sohn, Wolfgang Schepp, Felix Gundling. Role of Brain Biomarkers S-100-Beta and Neuron-Specific Enolase for Detection and Follow-Up of Hepatic Encephalopathy in Cirrhosis before, during and after Treatment with L-Ornithine-L-Aspartate. GE - Portuguese Journal of Gastroenterology 2020; 27(6): 391 doi: 10.1159/000507225
295
Vahid Sheikhi, Zahra Heidari. Low Vitamin D Level was Associated with Non-alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus. Shiraz E-Medical Journal 2021; 23(3) doi: 10.5812/semj.118125
296
Sandra Calixto-Tlacomulco, Ismael Luna-Reyes, Blanca Delgado-Coello, Roxana Gutiérrez-Vidal, Juan Pablo Reyes-Grajeda, Jaime Mas-Oliva. CETP-derived Peptide Seq-1, the Key Component of HB-ATV-8 Vaccine Prevents Stress Responses, and Promotes Downregulation of Pro-Fibrotic Genes in Hepatocytes and Stellate Cells. Archives of Medical Research 2024; 55(2): 102937 doi: 10.1016/j.arcmed.2023.102937
297
Emilie S. Zoltick, Stephanie A. Smith-Warner, Chen Yuan, Molin Wang, Charles S. Fuchs, Jeffrey A. Meyerhardt, Andrew T. Chan, Kimmie Ng, Shuji Ogino, Meir J. Stampfer, Edward L. Giovannucci, Kana Wu. Sugar-sweetened beverage, artificially sweetened beverage and sugar intake and colorectal cancer survival. British Journal of Cancer 2021; 125(7): 1016 doi: 10.1038/s41416-021-01487-7
298
Eric M Sieloff, Brian Rutledge, Cuyler Huffman, Duncan Vos, Thomas Melgar. National trends and outcomes of genetically inherited non-alcoholic chronic liver disease in the USA: estimates from the National Inpatient Sample (NIS) database. Gastroenterology Report 2021; 9(1): 38 doi: 10.1093/gastro/goaa091
299
Hira Hanif, Muzammil M. Khan, Mukarram J. Ali, Pir A. Shah, Jinendra Satiya, Daryl T.Y. Lau, Aysha Aslam. A New Endemic of Concomitant Nonalcoholic Fatty Liver Disease and Chronic Hepatitis B. Microorganisms 2020; 8(10): 1526 doi: 10.3390/microorganisms8101526
300
Yunjung Choi, Chang Hun Lee, In Hee Kim, Eun Hae Park, SoJeong Park, Wan-Hee Yoo. Methotrexate use does not increase the prevalence of hepatic steatosis: a real-world retrospective nested case-control study. Clinical Rheumatology 2021; 40(5): 2037 doi: 10.1007/s10067-020-05456-y
301
Qin Liu, Chun-Yan Niu. From “two hit theory” to “multiple hit theory”: Implications of evolution of pathogenesis concepts for treatment of non-alcoholic fatty liver disease. World Chinese Journal of Digestology 2019; 27(19): 1171 doi: 10.11569/wcjd.v27.i19.1171
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
302
Cheng Zhou, Wenji Zhang, Hui Lin, Luyun Zhang, Fan Wu, Yan Wang, Susu Yu, Xinyue Peng, Wenli Cheng, Min Li, Xiaoying Pan, Zhenrui Huang, Wenjuan Zhang. Effect of theaflavin-3,3′-digallate on leptin-deficient induced nonalcoholic fatty liver disease might be related to lipid metabolism regulated by the Fads1/PPARδ/Fabp4 axis and gut microbiota. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.925264
303
Seung Mi Yeo, Joo Hyun Oh, Hee Ju Yu, Dong Hyun Sinn, Ji Hye Hwang. The effect of mHealth-based exercise on Insulin Sensitivity for patients with Hepatocellular carcinoma and insulin resistance (mISH): protocol of a randomized controlled trial. Trials 2022; 23(1) doi: 10.1186/s13063-022-06858-w
304
John C. Parker, Andreas G. Moraitis, Joseph K. Belanoff. Biochemical and Radiological Changes in Liver Steatosis Following Mifepristone Treatment in Patients With Hypercortisolism. AACE Clinical Case Reports 2022; 8(1): 25 doi: 10.1016/j.aace.2021.07.001
305
Eduardo E. Vargas-Pozada, Erika Ramos-Tovar, Juan D. Rodriguez-Callejas, Irina Cardoso-Lezama, Silvia Galindo-Gómez, Karla Gil-Becerril, Verónica Rocío Vásquez-Garzón, Jaime Arellanes-Robledo, Víctor Tsutsumi, Saúl Villa-Treviño, Pablo Muriel. Activation of the NLRP3 inflammasome by CCl4 exacerbates hepatopathogenic diet-induced experimental NASH. Annals of Hepatology 2023; 28(1): 100780 doi: 10.1016/j.aohep.2022.100780
306
Mina Karimi, Behnaz Abiri, Paul C. Guest, Mohammadreza Vafa. Physical Exercise and Natural and Synthetic Products in Health and Disease. Methods in Molecular Biology 2022; 2343: 19 doi: 10.1007/978-1-0716-1558-4_2
307
Yuhan Zhang, Lusi Xu, Yiran Lu, Jing Zhang, Mengge Yang, Yutian Tian, Jianjun Dong, Lin Liao. Protective effect of Cordyceps sinensis against diabetic kidney disease through promoting proliferation and inhibiting apoptosis of renal proximal tubular cells. BMC Complementary Medicine and Therapies 2023; 23(1) doi: 10.1186/s12906-023-03901-4
308
Duck Min Seo, Sang Min Lee, Ji Won Park, Min-Jeong Kim, Hong Il Ha, Sun-Young Park, Kwanseop Lee. How many times should we repeat measurements of the ultrasound-guided attenuation parameter for evaluating hepatic steatosis?. Ultrasonography 2023; 42(2): 227 doi: 10.14366/usg.22122
309
Kiarash Riazi, Hassan Azhari, Jacob H. Charette, Fox E. Underwood, James A. King, Elnaz Ehteshami Afshar, Mark G. Swain, Stephen E. Congly, Gilaad G. Kaplan, Abdel Aziz Shaheen. The Worldwide Burden of NAFLD: A Systematic Review and Meta-Analysis of Prevalence and Incidence. SSRN Electronic Journal 2022;  doi: 10.2139/ssrn.4002396
310
Mariana F. Leite, Ariele B. Haagsma, Paulo-André B. Machado-Júnior, Grasiele L. Martins, Márcia Olandoski, Cristina P. Baena. Association between serum uric acid levels and incidence of nonalcoholic fatty liver disease in users of preventive medicine service in southern Brazil: a retrospective study. Bulletin of the National Research Centre 2022; 46(1) doi: 10.1186/s42269-022-00848-3
311
Kun Lian, Yu‐Nan Feng, Rong Li, Hao‐Lin Liu, Peng Han, Lei Zhou, Cheng‐Xiang Li, Qin Wang. Middle‐ and high‐molecular weight adiponectin levels in relation to nonalcoholic fatty liver disease. Journal of Clinical Laboratory Analysis 2020; 34(4) doi: 10.1002/jcla.23148
312
Effect of vanillic acid and exercise training on fatty liver and insulin resistance in rats: Possible role of fibroblast growth factor 21 and autophagy. Physiology International 2021; 108(4): 412 doi: 10.1556/2060.2021.00188
313
Zhe Jiang, Takuya Hayashi, Kentaro Kashima, Kayo Kurotani, Bungo Shirouchi, Tetsuya Mizoue, Masao Sato. Alteration of Serum Phospholipid n‐6 Polyunsaturated Fatty Acid Compositions in Nonalcoholic Fatty Liver Disease in the Japanese Population: A Cross‐Sectional Study. Lipids 2020; 55(6): 599 doi: 10.1002/lipd.12251
314
Sayuri Yoshikawa, Kurumi Taniguchi, Haruka Sawamura, Yuka Ikeda, Tomoko Asai, Ai Tsuji, Satoru Matsuda. Metabolic Associated Fatty Liver Disease as a Risk Factor for the Development of Central Nervous System Disorders. Livers 2023; 3(1): 21 doi: 10.3390/livers3010002
315
Leen J. M. Heyens, Dana Busschots, Ger H. Koek, Geert Robaeys, Sven Francque. Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.615978
316
David M. Rodrigues, Arjun Kundra, Lawrence Hookey, Steven Montague. Does Point-of-Care Ultrasound Change the Needle Insertion Location During Routine Bedside Paracentesis?. Journal of General Internal Medicine 2022; 37(7): 1598 doi: 10.1007/s11606-021-07042-7
317
Robert N. Helsley, Se-Hyung Park, Hemendra J. Vekaria, Patrick G. Sullivan, Lindsey R. Conroy, Ramon C. Sun, María del Mar Romero, Laura Herrero, Joanna Bons, Christina D. King, Jacob Rose, Jesse G. Meyer, Birgit Schilling, C. Ronald Kahn, Samir Softic. Ketohexokinase-C regulates global protein acetylation to decrease carnitine palmitoyltransferase 1a-mediated fatty acid oxidation. Journal of Hepatology 2023; 79(1): 25 doi: 10.1016/j.jhep.2023.02.010
318
Khara Lucius. Nutritional and Botanical Approaches for Nonalcoholic Fatty Liver Disease. Alternative and Complementary Therapies 2020; 26(6): 246 doi: 10.1089/act.2020.29303.klu
319
Xinhe Zhang, Haoyu Tian, Yiling Li. The pathophysiological mechanism between hypopituitarism and nonalcoholic fatty liver disease. iLIVER 2022; 1(1): 65 doi: 10.1016/j.iliver.2022.02.004
320
Lu Fan, Hongjuan Niu, Linyi Zhao, Rongfei Yao, Xu He, Binan Lu, Zongran Pang. Purendan alleviates non-alcoholic fatty liver disease in aged type 2 diabetic rats via regulating mTOR/S6K1/SREBP-1c signaling pathway. Biomedicine & Pharmacotherapy 2022; 148: 112697 doi: 10.1016/j.biopha.2022.112697
321
Ahmed Hashem, Yogesh Shastri, Malfi Al Otaibi, Elwin Buchel, Hussam Saleh, Reyaz Ahmad, Hamouda Ahmed, Fateh Al Idris, Saleh Ahmed, Mohamed Guda, Anton Gillessen. Expert Opinion on the Management of Non-Alcoholic Fatty Liver Disease (NAFLD) in the Middle East with a Focus on the Use of Silymarin. Gastroenterology Insights 2021; 12(2): 155 doi: 10.3390/gastroent12020014
322
Fangfei Xie, Yuyu Pei, Quan Zhou, Deli Cao, Yun Wang. Comparison of obesity-related indices for identifying nonalcoholic fatty liver disease: a population-based cross-sectional study in China. Lipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01560-3
323
Sisi Yan, Sha Liu, Jianyu Qu, Xiaowen Li, Jiahao Hu, Linyu Zhang, Xiangyan Liu, Xin Li, Xianglin Wang, Lixin Wen, Ji Wang. A Lard and Soybean Oil Mixture Alleviates Low-Fat–High-Carbohydrate Diet-Induced Nonalcoholic Fatty Liver Disease in Mice. Nutrients 2022; 14(3): 560 doi: 10.3390/nu14030560
324
Raj Shah, Sagarika Satyavada, Perica Davitkov. Nutrition, Weight, and Digestive Health. 2022; : 107 doi: 10.1007/978-3-030-94953-2_7
325
Olfa Khalifa, Khalid Ouararhni, Khaoula Errafii, Nehad M. Alajez, Abdelilah Arredouani. Targeted MicroRNA Profiling Reveals That Exendin-4 Modulates the Expression of Several MicroRNAs to Reduce Steatosis in HepG2 Cells. International Journal of Molecular Sciences 2023; 24(14): 11606 doi: 10.3390/ijms241411606
326
Alexander Kusnik, Nicole Hunter, Erik Rasbach, Thomas Miethke, Christoph Reissfelder, Matthias Philip Ebert, Andreas Teufel. Co-Medication and Nutrition in Hepatocellular Carcinoma: Potentially Preventative Strategies in Hepatocellular Carcinoma. Digestive Diseases 2021; 39(5): 526 doi: 10.1159/000514277
327
Wiebke Breternitz, Friedrich Sandkühler, Frauke Grohmann, Jochen Hampe, Mario Brosch, Alexander Herrmann, Clemens Schafmayer, Christian Meinhardt, Stefan Schreiber, Alexander Arlt, Claudia Geismann. The HSF1-CPT1a Pathway Is Differentially Regulated in NAFLD Progression. Cells 2022; 11(21): 3504 doi: 10.3390/cells11213504
328
Isabel Molwitz, Miriam Leiderer, Cansu Özden, Jin Yamamura. Dual-Energy Computed Tomography for Fat Quantification in the Liver and Bone Marrow: A Literature Review. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren 2020; 192(12): 1137 doi: 10.1055/a-1212-6017
329
Yusuf Yilmaz, Christopher D. Byrne, Giovanni Musso. A single-letter change in an acronym: signals, reasons, promises, challenges, and steps ahead for moving from NAFLD to MAFLD. Expert Review of Gastroenterology & Hepatology 2021; 15(4): 345 doi: 10.1080/17474124.2021.1860019
330
Kazuma Mori, Marenao Tanaka, Yukimura Higashiura, Nagisa Hanawa, Hirofumi Ohnishi, Masato Furuhashi. High fatty liver index is an independent predictor of ischemic heart disease during a 10‐year period in a Japanese population. Hepatology Research 2022; 52(8): 687 doi: 10.1111/hepr.13790
331
Mak-Soon Lee, Cheamin Kim, Hyunmi Ko, Yangha Kim. Inhibitory effect of water-soluble mulberry leaf extract on hepatic lipid accumulation in high-fat diet-fed rats via modulation of hepatic microRNA-221/222 expression and inflammation. Journal of Nutrition and Health 2022; 55(2): 227 doi: 10.4163/jnh.2022.55.2.227
332
Aldo J. Montaño-Loza. Evaluación de la fibrosis en pacientes con enfermedad de hígado graso no alcohólico. Revista de Gastroenterología de México 2022; 87(1): 1 doi: 10.1016/j.rgmx.2021.04.004
333
Karl Nadolsky, Donna R. Cryer, Amy Articolo, Travis Fisher, Jennifer Schneider, Mary Rinella. Nonalcoholic steatohepatitis diagnosis and treatment from the perspective of patients and primary care physicians: a cross-sectional survey. Annals of Medicine 2023; 55(1) doi: 10.1080/07853890.2023.2211349
334
Doina Georgescu, Ana Lascu, Ioana Ionita, Oana-Elena Ancusa, Mihai Ionita, Ciprian Rosca, Despina Calamar-Popovici, Daniel Lighezan. Advances in Probiotics for Health and Nutrition. 2024;  doi: 10.5772/intechopen.110134
335
Zizuo Zhao, Tiankuo Luan, Jingyuan Wan, Hui Du, Jun Hu, Hao Liu, Xia Gong, Ge Kuang, Bin Wang. Elucidating Cuproptosis-Associated Genes in the Progression from Nash to HCC Using Bulk and Single-Cell RNA Sequencing Analyses and Experimental Validation. Medicina 2023; 59(9): 1639 doi: 10.3390/medicina59091639
336
Hejun Li, Ying Zhang, Hengcong Luo, Rong Lin. The lipid accumulation product is a powerful tool to diagnose metabolic dysfunction-associated fatty liver disease in the United States adults. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.977625
337
Arun J. Sanyal, Jérémy Magnanensi, Zouher Majd, Christian Rosenquist, Delphis M. Vera, James P. Almas, Margery A. Connelly. NIS2+™, an effective blood-based test for the diagnosis of at-risk nonalcoholic steatohepatitis in adults 65 years and older. Hepatology Communications 2023; 7(9) doi: 10.1097/HC9.0000000000000223
338
Teresa Vanessa Fiorentino, Elena Succurro, Angela Sciacqua, Francesco Andreozzi, Francesco Perticone, Giorgio Sesti. Non‐alcoholic fatty liver disease is associated with cardiovascular disease in subjects with different glucose tolerance. Diabetes/Metabolism Research and Reviews 2020; 36(8) doi: 10.1002/dmrr.3333
339
Jiayun M. Fang, Jerome Cheng, Michael F. Chang, Joseph Ahn, Maria Westerhoff. Transient elastography versus liver biopsy: discordance in evaluations for fibrosis and steatosis from a pathology standpoint. Modern Pathology 2021; 34(10): 1955 doi: 10.1038/s41379-021-00851-5
340
Vania Morales, Andrea González, Claudio Cabello-Verrugio. Advances in Molecular Pathology. Advances in Experimental Medicine and Biology 2023; 1408: 201 doi: 10.1007/978-3-031-26163-3_11
341
Robert J. Wong, Nandita Kachru, Diane J. Martinez, Meghan Moynihan, A. Burak Ozbay, Stuart C. Gordon. Real-world Comorbidity Burden, Health Care Utilization, and Costs of Nonalcoholic Steatohepatitis Patients With Advanced Liver Diseases. Journal of Clinical Gastroenterology 2021; 55(10): 891 doi: 10.1097/MCG.0000000000001409
342
M. Zhao, Y. Hu, C. Shi, K. Wang, J. Li, J. Song, C. Huo, Y. Xi, S. Bu, Q. Huang. NFI, a clinical scoring tool for predicting non-alcoholic fatty liver in the Chinese population. Public Health 2022; 202: 12 doi: 10.1016/j.puhe.2021.10.012
343
Veera Houttu, Julia Bouts, Yasaman Vali, Joost Daams, Aldo Grefhorst, Max Nieuwdorp, Adriaan G. Holleboom. Does aerobic exercise reduce NASH and liver fibrosis in patients with non-alcoholic fatty liver disease? A systematic literature review and meta-analysis. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1032164
344
Nikta Afzali, Seyed Shayan Ebadi, Hasan Afzali, Mohammad Reza Sharif, Mahdi Vazirian, Seyed Alireza Ebadi, Vahid Shahkarami, Habibollah Rahimi. Effect of Beta vulgaris Extract on Liver Enzymes in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial. Hepatitis Monthly 2020; 20(7) doi: 10.5812/hepatmon.102125
345
Changhui Yu, Shiming He, Maobin Kuang, Chao Wang, Xin Huang, Guotai Sheng, Yang Zou. Association between weight-adjusted waist index and non-alcoholic fatty liver disease: a population-based study. BMC Endocrine Disorders 2024; 24(1) doi: 10.1186/s12902-024-01554-z
346
Hannah R. McDowell, Cher Shiong Chuah, Dhiraj Tripathi, Adrian J. Stanley, Ewan H. Forrest, Peter C. Hayes. Carvedilol is associated with improved survival in patients with cirrhosis: a long‐term follow‐up study. Alimentary Pharmacology & Therapeutics 2021; 53(4): 531 doi: 10.1111/apt.16189
347
Yuqin Zhang, Liping Hua, Chunfeng Lin, Mingzhou Yuan, Wei Xu, Anand Raj D., Baskar Venkidasamy, Carlos L. Cespedes-Acuna, Shivraj Hariram Nile, Guohong Yan, Haiyin Zheng. Pien-Tze-Huang alleviates CCl4-induced liver fibrosis through the inhibition of HSC autophagy and the TGF-β1/Smad2 pathway. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.937484
348
Teresa Y. Oh, Sirish Palle, A. Jay Freeman. Update in Pediatrics. 2023; : 399 doi: 10.1007/978-3-031-41542-5_16
349
Ping Chen, Yusheng Li, Li Xiao. Berberine ameliorates nonalcoholic fatty liver disease by decreasing the liver lipid content via reversing the abnormal expression of MTTP and LDLR. Experimental and Therapeutic Medicine 2021; 22(4) doi: 10.3892/etm.2021.10543
350
Sara Karjoo, Anthony Auriemma, Teresa Fraker, Harold Edward Bays. Nonalcoholic fatty liver disease and obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022. Obesity Pillars 2022; 3: 100027 doi: 10.1016/j.obpill.2022.100027
351
Derek J. Erstad, Allen A. Razavi, Shen Li, Kenneth K. Tanabe, Bryan C. Fuchs. Hepatocellular Carcinoma. Molecular and Translational Medicine 2019; : 255 doi: 10.1007/978-3-030-21540-8_13
352
Lyssia Castellanos-Tapia, María Elizabeth Tejero-Barrera, Soraya Salas-Silva, Arturo Simoni-Nieves, Alejandro Escobedo-Calvario, Luis E. Gomez-Quiroz. Mediterranean-like mix of fatty acids induces cellular protection on lipid-overloaded hepatocytes from western diet fed mice. Annals of Hepatology 2020; 19(5): 489 doi: 10.1016/j.aohep.2020.06.005
353
Kabelo Mokgalaboni, Yonela Ntamo, Khanyisani Ziqubu, Tawanda M. Nyambuya, Bongani B. Nkambule, Sithandiwe E. Mazibuko-Mbeje, Kwazikwakhe B. Gabuza, Nireshni Chellan, Luca Tiano, Phiwayinkosi V. Dludla. Curcumin supplementation improves biomarkers of oxidative stress and inflammation in conditions of obesity, type 2 diabetes and NAFLD: updating the status of clinical evidence. Food & Function 2021; 12(24): 12235 doi: 10.1039/D1FO02696H
354
G. Fadieienko, А. Gridnev, I. Kushnir, T. Solomentseva, V. Chernova, V. Galchіnskaya. The Role of Intestinal Microbiota, Endotoxemia and Systemic Inflammation in the Pathogenesis of Nonalcoholic Fatty Liver Disease. Lviv clinical bulletin 2023; (39-40): 8 doi: 10.25040/lkv2022.03-04.008
355
Viktoriya Bikeyeva, Ahmed Abdullah, Aleksandra Radivojevic, Anas A Abu Jad, Anvesh Ravanavena, Chetna Ravindra, Emmanuelar O Igweonu-Nwakile, Safina Ali, Salomi Paul, Shreyas Yakkali, Sneha Teresa Selvin, Sonu Thomas, Pousette Hamid. Nonalcoholic Fatty Liver Disease and Hypothyroidism: What You Need to Know . Cureus 2022;  doi: 10.7759/cureus.28052
356
Hee Jin Jeong, Song Hee Lee, Hee Eun Kang. Changes in digoxin pharmacokinetics associated with hepatic P‐glycoprotein upregulation in rats with non‐alcoholic fatty liver disease. Fundamental & Clinical Pharmacology 2021; 35(6): 1100 doi: 10.1111/fcp.12687
357
Jacob J. Swidorski, Brett R. Beno, Chunjian Liu, David S. Yoon, Kaushik Ghosh, Harinath Sale, Devang Shah, Kriti Acharya, Joseph Yanchunas, Priyanka Haldar, Narasimharaju Kalidindi, Jinal K. Shukla, Matthew Argentieri, Bruce A. Ellsworth, Dong Cheng, Alicia Regueiro-Ren. Discovery and exploration of monosaccharide linked dimers of galectin-3 inhibitors to target fibrosis. Medicinal Chemistry Research 2023; 32(7): 1453 doi: 10.1007/s00044-023-03087-x
358
Emine Turkkan, Huseyin Dag, Okan Dikker, Nevin Cetin Dag, Alper Kacar, Soner Sazak. Omentin-1 Levels and Non-alcoholic Fatty Liver Disease in Obese Adolescents. Iranian Journal of Pediatrics 2021; 31(5) doi: 10.5812/ijp.117353
359
Soumya Murag, Aijaz Ahmed, Donghee Kim. Recent Epidemiology of Nonalcoholic Fatty Liver Disease. Gut and Liver 2021; 15(2): 206 doi: 10.5009/gnl20127
360
Fatemeh Haidari, Abdollah Hojhabrimanesh, Bizhan Helli, Seyed-Saeed Seyedian, Kambiz Ahmadi-Angali. An energy-restricted high-protein diet supplemented with β-cryptoxanthin alleviated oxidative stress and inflammation in nonalcoholic fatty liver disease: a randomized controlled trial. Nutrition Research 2020; 73: 15 doi: 10.1016/j.nutres.2019.08.009
361
Aldo J. Montaño-Loza. Evaluation of fibrosis in patients with nonalcoholic fatty liver disease. Revista de Gastroenterología de México (English Edition) 2022; 87(1): 1 doi: 10.1016/j.rgmxen.2021.10.004
362
Shan Dang, Jian Zhou, Zongyan Wang, Kunning Wang, Shejiao Dai, Shuixiang He. MiR-299-3p functions as a tumor suppressor via targeting Sirtuin 5 in hepatocellular carcinoma. Biomedicine & Pharmacotherapy 2018; 106: 966 doi: 10.1016/j.biopha.2018.06.042
363
Minhee Lee, Dakyung Kim, So Jung Park, Kyung Seok Kim, Geum Duck Park, Ok-Kyung Kim, Jeongmin Lee. Artichoke Extract Directly Suppresses Inflammation and Apoptosis in Hepatocytes During the Development of Non-Alcoholic Fatty Liver Disease. Journal of Medicinal Food 2021; 24(10): 1083 doi: 10.1089/jmf.2021.K.0069
364
Aref Yarahmadi, Hamed Afkhami. The role of microbiomes in gastrointestinal cancers: new insights. Frontiers in Oncology 2024; 13 doi: 10.3389/fonc.2023.1344328
365
Lin Wei, Hui-Guo Ding. Relationship between Helicobacter pylori infection and nonalcoholic fatty liver disease. Medicine 2021; 100(31): e26706 doi: 10.1097/MD.0000000000026706
366
Helena Julià, David Benaiges, Juan Pedro-Botet. Bariatric surgery and non-alcoholic fatty liver disease. Medicina Clínica 2022; 158(11): 550 doi: 10.1016/j.medcli.2021.12.003
367
Sydney Pomenti, Cassandra Gandle, Hamzah Abu Sbeih, Meaghan Phipps, Alexandra Livanos, Averill Guo, Jonathan Yeh, Heather Burney, Hao Liu, Lara Dakhoul, Carla Kettler, Samer Gawrieh, Andrew deLemos, Andrew Scanga, Naga Chalasani, Ethan Miller, Julia Wattacheril. Hepatocellular Carcinoma in Hispanic Patients: Trends and Outcomes in a Large United States Cohort. Hepatology Communications 2020; 4(11): 1708 doi: 10.1002/hep4.1575
368
Allyce Caines, Ranya Selim, Reena Salgia. The Changing Global Epidemiology of Hepatocellular Carcinoma. Clinics in Liver Disease 2020; 24(4): 535 doi: 10.1016/j.cld.2020.06.001
369
María Juárez-Fernández, David Porras, María García-Mediavilla, Sara Román-Sagüillo, Javier González-Gallego, Esther Nistal, Sonia Sánchez-Campos. Aging, Gut Microbiota and Metabolic Diseases: Management through Physical Exercise and Nutritional Interventions. Nutrients 2020; 13(1): 16 doi: 10.3390/nu13010016
370
J. Bronsard, C. Savary, J. Massart, R. Viel, L. Moutaux, D. Catheline, V. Rioux, B. Clement, A. Corlu, B. Fromenty, P.J. Ferron. 3D multi-cell-type liver organoids: A new model of non-alcoholic fatty liver disease for drug safety assessments. Toxicology in Vitro 2024; 94: 105728 doi: 10.1016/j.tiv.2023.105728
371
Verena C Obmann, Christina Marx, Annalisa Berzigotti, Nando Mertineit, Joris Hrycyk, Christoph Gräni, Lukas Ebner, Michael Ith, Johannes T Heverhagen, Andreas Christe, Adrian T Huber. Liver MRI susceptibility-weighted imaging (SWI) compared to T2* mapping in the presence of steatosis and fibrosis. European Journal of Radiology 2019; 118: 66 doi: 10.1016/j.ejrad.2019.07.001
372
Rebecca K. Vincent, David M. Williams, Marc Evans. A look to the future in non‐alcoholic fatty liver disease: Are glucagon‐like peptide‐1 analogues or sodium‐glucose co‐transporter‐2 inhibitors the answer?. Diabetes, Obesity and Metabolism 2020; 22(12): 2227 doi: 10.1111/dom.14196
373
Simeng Wang, Qingzhang Zhu, Guosheng Liang, Tania Franks, Magalie Boucher, Kendra K. Bence, Mingjian Lu, Carlos M. Castorena, Shangang Zhao, Joel K. Elmquist, Philipp E. Scherer, Jay D. Horton. Cannabinoid receptor 1 signaling in hepatocytes and stellate cells does not contribute to NAFLD. Journal of Clinical Investigation 2021; 131(22) doi: 10.1172/JCI152242
374
Sangwon F. Kim, Jang Hyun Choi. Metabolic Syndrome. 2023; : 567 doi: 10.1007/978-3-031-40116-9_36
375
Lauren A. Newman, Michael J. Sorich, Andrew Rowland. Role of Extracellular Vesicles in the Pathophysiology, Diagnosis and Tracking of Non-Alcoholic Fatty Liver Disease. Journal of Clinical Medicine 2020; 9(7): 2032 doi: 10.3390/jcm9072032
376
Ioannis Ilias, Spyridon Goulas, Lina Zabuliene. Polycystic ovary syndrome: Pathways and mechanisms for possible increased susceptibility to COVID-19. World Journal of Clinical Cases 2021; 9(12): 2711-2720 doi: 10.12998/wjcc.v9.i12.2711
377
Yuan Liu, Jinxin Zheng, Jialing Hao, Rang Rang Wang, Xueni Liu, Peng Gu, Hongwei Yu, Yang Yu, Chuanxing Wu, Baochi Ou, Zhihai Peng. Global burden of primary liver cancer by five etiologies and global prediction by 2035 based on global burden of disease study 2019. Cancer Medicine 2022; 11(5): 1310 doi: 10.1002/cam4.4551
378
Yan-yun Shu, Wen-kang Gao, Hui-kuan Chu, Ling Yang, Xiao-li Pan, Jin Ye, Lianxiang Luo. Attenuation by Time-Restricted Feeding of High-Fat and High-Fructose Diet-Induced NASH in Mice Is Related to Per2 and Ferroptosis. Oxidative Medicine and Cellular Longevity 2022; 2022: 1 doi: 10.1155/2022/8063897
379
Ewa Rudnicka, Anna Maria Duszewska, Marek Kucharski, Paweł Tyczyński, Roman Smolarczyk. OXIDATIVE STRESS AND REPRODUCTIVE FUNCTION: Oxidative stress in polycystic ovary syndrome. Reproduction 2022; 164(6): F145 doi: 10.1530/REP-22-0152
380
Zahra Heidari, Zahra Sharafi. Association of Non-Alcoholic Fatty Liver Dis-ease and Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus: a Cross-Sectional Study. Iranian South Medical Journal 2022; 25(1): 30 doi: 10.52547/ismj.25.1.30
381
Taisiia Turankova, Oleg Blyuss, Alexey Brazhnikov, Andrey Svistunov, Kurinchi Selvan Gurusamy, Chavdar S Pavlov. Transient elastography with controlled attenuation parameter (CAP) for diagnosis of moderate or severe steatosis in people with suspected non-alcoholic fatty liver disease. Cochrane Database of Systematic Reviews 2020;  doi: 10.1002/14651858.CD013670
382
Marc Evans, Angharad R. Morgan, Dipesh Patel, Ketan Dhatariya, Sharlene Greenwood, Philip Newland-Jones, Debbie Hicks, Zaheer Yousef, Jim Moore, Bethany Kelly, Sarah Davies, Umesh Dashora. Risk Prediction of the Diabetes Missing Million: Identifying Individuals at High Risk of Diabetes and Related Complications. Diabetes Therapy 2021; 12(1): 87 doi: 10.1007/s13300-020-00963-2
383
Enxiang Zhang, Shutao Yin, Shuang Zhao, Chong Zhao, Mingzhu Yan, Lihong Fan, Hongbo Hu. Protective effects of glycycoumarin on liver diseases. Phytotherapy Research 2020; 34(6): 1191 doi: 10.1002/ptr.6598
384
Weiwei Zhu, Namood E Sahar, Hafiz Muhammad Ahmad Javaid, Eun Seon Pak, Guang Liang, Yi Wang, Hunjoo Ha, Joo Young Huh. Exercise-Induced Irisin Decreases Inflammation and Improves NAFLD by Competitive Binding with MD2. Cells 2021; 10(12): 3306 doi: 10.3390/cells10123306
385
Antoni Sureda, Xavier Capó, Silvia Tejada. Influence of Nutrients, Bioactive Compounds, and Plant Extracts in Liver Diseases. 2021; : 83 doi: 10.1016/B978-0-12-816488-4.00007-3
386
Andrew M. Moon, Stephanie E. Watkins, Anna S. Lok, Roberto J. Firpi-Morell, Huy Ngoc Trinh, Justin T. Kupec, Cheryl Schoen, Brent A. Neuschwander-Tetri, A. Sidney Barritt. Opioid Use Is More Common in Nonalcoholic Fatty Liver Disease Patients with Cirrhosis, Higher BMI, and Psychiatric Disease. Digestive Diseases 2021; 39(3): 247 doi: 10.1159/000511074
387
Aman Sharma. Lipid droplets associated perilipins protein insights into finding a therapeutic target approach to cure non-alcoholic fatty liver disease (NAFLD). Future Journal of Pharmaceutical Sciences 2022; 8(1) doi: 10.1186/s43094-021-00395-0
388
Athanasia Mitsala, Christos Tsalikidis, Konstantinos Romanidis, Michail Pitiakoudis. Non-Alcoholic Fatty Liver Disease and Extrahepatic Cancers: A Wolf in Sheep’s Clothing?. Current Oncology 2022; 29(7): 4478 doi: 10.3390/curroncol29070356
389
Mahesh Mathew, Zachary C. Pope, Pamela J. Schreiner, David R. Jacobs, Lisa B. VanWagner, James G. Terry, Mark A. Pereira. Non‐alcoholic fatty liver modifies associations of body mass index and waist circumference with cardiometabolic risk: The CARDIA study. Obesity Science & Practice 2024; 10(2) doi: 10.1002/osp4.751
390
Elham Karimi-Sales, Sajad Jeddi, Mohammad Reza Alipour. trans-Chalcone inhibits transforming growth factor-β1 and connective tissue growth factor-dependent collagen expression in the heart of high-fat diet-fed rats. Archives of Physiology and Biochemistry 2022; 128(5): 1221 doi: 10.1080/13813455.2020.1764045
391
Jarren R. Oates, Melanie C. McKell, Maria E. Moreno-Fernandez, Michelle S. M. A. Damen, George S. Deepe, Joseph E. Qualls, Senad Divanovic. Macrophage Function in the Pathogenesis of Non-alcoholic Fatty Liver Disease: The Mac Attack. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.02893
392
Xuan G. Luong, Sarah K. Stevens, Andreas Jekle, Tse-I Lin, Kusum Gupta, Dinah Misner, Sushmita Chanda, Sucheta Mukherjee, Caroline Williams, Antitsa Stoycheva, Lawrence M. Blatt, Leonid N. Beigelman, Julian A. Symons, Pierre Raboisson, David McGowan, Koen Vandyck, Jerome Deval, Olivier Barbier. Regulation of gene transcription by thyroid hormone receptor β agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH). PLOS ONE 2020; 15(12): e0240338 doi: 10.1371/journal.pone.0240338
393
Cayden Beyer, Chloe Hutton, Anneli Andersson, Kento Imajo, Atsushi Nakajima, Dustin Kiker, Rajarshi Banerjee, Andrea Dennis, Wan-Long Chuang. Comparison between magnetic resonance and ultrasound-derived indicators of hepatic steatosis in a pooled NAFLD cohort. PLOS ONE 2021; 16(4): e0249491 doi: 10.1371/journal.pone.0249491
394
Associated Liver Disease in Alcoholic Chronic Pancreatitis. Academia Journal of Surgery 2020; 3(1): 172 doi: 10.47008/ajs/2020.3.1.37
395
Vasile-Andrei Olteanu, Gheorghe G. Balan, Oana Timofte, Cristina Gena Dascalu, Elena Gologan, Georgiana-Emanuela Gilca-Blanariu, Madalina-Maria Diac, Ion Sandu, Gabriela Stefanescu. Risk Predictors of Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease. Diagnostics 2022; 12(9): 2136 doi: 10.3390/diagnostics12092136
396
Yesmi A. Ortega Rojas, Claudia L. Vidal Cuellar, Karina M. Aparicio Barrón, Juan Pablo Arab, Adelina Lozano Miranda. Non-alcoholic fatty liver disease prevalence in Latin America: A systematic review and meta-analysis. Annals of Hepatology 2022; 27(6): 100706 doi: 10.1016/j.aohep.2022.100706
397
Joseph M. Salamoun, Christopher J. Garcia, Stefan R. Hargett, Jacob H. Murray, Sing-Young Chen, Martina Beretta, Stephanie J. Alexopoulos, Divya P. Shah, Ellen M. Olzomer, Simon P. Tucker, Kyle L. Hoehn, Webster L. Santos. 6-Amino[1,2,5]oxadiazolo[3,4-b]pyrazin-5-ol Derivatives as Efficacious Mitochondrial Uncouplers in STAM Mouse Model of Nonalcoholic Steatohepatitis. Journal of Medicinal Chemistry 2020; 63(11): 6203 doi: 10.1021/acs.jmedchem.0c00542
398
Yu Chung Chooi, Qinze Arthur Zhang, Faidon Magkos, Maisie Ng, Navin Michael, Xiaorong Wu, Vera Sergeyevna Brok Volchanskaya, Xianning Lai, Elvy Riani Wanjaya, Untzizu Elejalde, Chew Chan Goh, Clara Poh Lian Yap, Long Hui Wong, Kevin Junliang Lim, S. Sendhil Velan, Jadegoud Yaligar, Mark Dhinesh Muthiah, Yap Seng Chong, Evelyn Xiu Ling Loo, Johan G. Eriksson, Kezlyn Li Ming Lim, Mabel Shu Fung Kouk, Evelyn Wai Mei Chong, Munirah Abd Gani, Lisha Li, Vicky Hwee Kee Tay, Yeshe Manuel Kway, Mukkesh Kumar, Suresh Anand Sadananthan, Kaijie Khoo, Danyu Koh, Rebecca Lim, Chin Wei Kang, Kwang Li Sin, Jun Wei Lim. Effect of an Asian-adapted Mediterranean diet and pentadecanoic acid on fatty liver disease: the TANGO randomized controlled trial. The American Journal of Clinical Nutrition 2024; 119(3): 788 doi: 10.1016/j.ajcnut.2023.11.013
399
P. V. Koroy, Yu. A. Kravchenko, A. V. Yagoda. The possibilities of soluble selectins in the prediction of severe fi brosis in nonalcoholic fatty liver disease. Experimental and Clinical Gastroenterology 2022; (3): 50 doi: 10.31146/1682-8658-ecg-199-3-50-56
400
Eréndira Villanueva-Ortega, Lucia A. Méndez-García, Guadalupe N. Garibay-Nieto, Estibalitz Laresgoiti-Servitje, Patricia Medina-Bravo, Alfonso Olivos-García, Martín H. Muñoz-Ortega, Javier Ventura-Juárez, Galileo Escobedo. Growth hormone ameliorates high glucose-induced steatosis on in vitro cultured human HepG2 hepatocytes by inhibiting de novo lipogenesis via ChREBP and FAS suppression. Growth Hormone & IGF Research 2020; : 101332 doi: 10.1016/j.ghir.2020.101332
401
Banrida Wahlang, Savitri Appana, K. Cameron Falkner, Craig J. McClain, Guy Brock, Matthew C. Cave. Insecticide and metal exposures are associated with a surrogate biomarker for non-alcoholic fatty liver disease in the National Health and Nutrition Examination Survey 2003–2004. Environmental Science and Pollution Research 2020; 27(6): 6476 doi: 10.1007/s11356-019-07066-x
402
Alexandra Zaborowski, Helen M. Heneghan, Barbara Fiore, Anthony Stafford, Tom Gallagher, Justin Geoghegan, Donal Maguire, Emir Hoti. Neoadjuvant Chemoradiotherapy and Liver Transplantation for Unresectable Hilar Cholangiocarcinoma: The Irish Experience of the Mayo Protocol. Transplantation 2020; 104(10): 2097 doi: 10.1097/TP.0000000000003114
403
Christian S. Alvarez, Barry I. Graubard, Jake E. Thistle, Jessica L. Petrick, Katherine A. McGlynn. Attributable Fractions of Nonalcoholic Fatty Liver Disease for Mortality in the United States: Results From the Third National Health and Nutrition Examination Survey With 27 Years of Follow‐up. Hepatology 2020; 72(2): 430 doi: 10.1002/hep.31040
404
Florence Wong, K. Rajender Reddy, Jacqueline G. O’Leary, Guadalupe Garcia‐Tsao, Patrick S. Kamath, Jasmohan S. Bajaj. Reply. Liver Transplantation 2019; 25(10): 1586 doi: 10.1002/lt.25612
405
Victor Sánchez, Annette Brandt, Cheng Jun Jin, Dragana Rajcic, Anna Janina Engstler, Finn Jung, Anika Nier, Anja Baumann, Ina Bergheim. Fortifying Butterfat with Soybean Oil Attenuates the Onset of Diet-Induced Non-Alcoholic Steatohepatitis and Glucose Intolerance. Nutrients 2021; 13(3): 959 doi: 10.3390/nu13030959
406
Francesca De Vito, Velia Cassano, Elettra Mancuso, Elena Succurro, Marta Letizia Hribal, Angela Sciacqua, Francesco Andreozzi, Giorgio Sesti, Teresa Vanessa Fiorentino. Higher circulating levels of proneurotensin are associated with increased risk of incident NAFLD. Journal of Internal Medicine 2023; 294(3): 336 doi: 10.1111/joim.13651
407
Jana Hudcova, Syed Talha Qasmi, Robin Ruthazer, Ahsan Waqas, Syed Basit Haider, Roman Schumann. Early Allograft Dysfunction Following Liver Transplant: Impact of Obesity, Diabetes, and Red Blood Cell Transfusion. Transplantation Proceedings 2021; 53(1): 119 doi: 10.1016/j.transproceed.2020.02.168
408
Charlotte Wernicke, Anne Pohrt, Laura Pletsch-Borba, Konstantina Apostolopoulou, Silke Hornemann, Nina Meyer, Jürgen Machann, Christiana Gerbracht, Frank Tacke, Andreas FH Pfeiffer, Joachim Spranger, Knut Mai. Effect of unsaturated fat and protein intake on liver fat in people at risk of unhealthy aging: 1-year results of a randomized controlled trial. The American Journal of Clinical Nutrition 2023; 117(4): 785 doi: 10.1016/j.ajcnut.2023.01.010
409
Emerging Therapies and Therapeutic Targets for Composite Liver Disease: NASH. Current Topics in Medicinal Chemistry 2023; 23(21): 2027 doi: 10.2174/1568026623666230714113808
410
Timothy M.E. Davis. Diabetes and metabolic dysfunction-associated fatty liver disease. Metabolism 2021; 123: 154868 doi: 10.1016/j.metabol.2021.154868
411
Yongjia Li, Xinming Su, Nidhi Rohatgi, Yan Zhang, Jonathan R. Brestoff, Kooresh I. Shoghi, Yalin Xu, Clay F. Semenkovich, Charles A. Harris, Lindsay L. Peterson, Katherine N. Weibaecher, Steven L. Teitelbaum, Wei Zou. Hepatic lipids promote liver metastasis. JCI Insight 2020; 5(17) doi: 10.1172/jci.insight.136215
412
N. M. Delzenne, C. Knudsen, M. Beaumont, J. Rodriguez, A. M. Neyrinck, L. B. Bindels. Contribution of the gut microbiota to the regulation of host metabolism and energy balance: a focus on the gut–liver axis. Proceedings of the Nutrition Society 2019; 78(3): 319 doi: 10.1017/S0029665118002756
413
Olfa Khalifa, Khaoula Errafii, Nayla S. Al-Akl, Abdelilah Arredouani. Noncoding RNAs in Nonalcoholic Fatty Liver Disease: Potential Diagnosis and Prognosis Biomarkers. Disease Markers 2020; 2020: 1 doi: 10.1155/2020/8822859
414
Qianying Zuo, Nicole Hwajin Park, Jenna Kathryn Lee, Ashlie Santaliz-Casiano, Zeynep Madak-Erdogan. Navigating nonalcoholic fatty liver disease (NAFLD): Exploring the roles of estrogens, pharmacological and medical interventions, and life style. Steroids 2024; 203: 109330 doi: 10.1016/j.steroids.2023.109330
415
Parichehr Amiri, Sara Arefhosseini, Farnush Bakhshimoghaddam, Hannah Jamshidi Gurvan, Seyed Ahmad Hosseini. Mechanistic insights into the pleiotropic effects of butyrate as a potential therapeutic agent on NAFLD management: A systematic review. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.1037696
416
Toshihiro Sakai, Hiroyuki Ohba, Shingo Nishiyama, Takeharu Kakiuchi, Osamu Inoue, Hideo Tsukada. Sensitive and early detection of mitochondrial dysfunction in the liver of NASH model mice by PET imaging with 18F-BCPP-BF. EJNMMI Research 2018; 8(1) doi: 10.1186/s13550-018-0420-6
417
Qi Shao, Yiping Wu, Jing Ji, Tian Xu, Qiaoyu Yu, Chongyang Ma, Xuejing Liao, Fafeng Cheng, Xueqian Wang. Interaction Mechanisms Between Major Depressive Disorder and Non-alcoholic Fatty Liver Disease. Frontiers in Psychiatry 2021; 12 doi: 10.3389/fpsyt.2021.711835
418
Fan Yang, Ping Huang, Liandong Shi, Feng Liu, Aimei Tang, Shaohui Xu. <p>Phoenixin 14 Inhibits High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Experimental Mice</p>. Drug Design, Development and Therapy 2020; : 3865 doi: 10.2147/DDDT.S258857
419
T. V. Fiorentino, S. Miceli, E. Succurro, A. Sciacqua, F. Andreozzi, G. Sesti. Nonalcoholic fatty liver disease is associated with a decreased myocardial mechano‐energetic efficiency. Journal of Internal Medicine 2021; 289(2): 221 doi: 10.1111/joim.13155
420
Dayana Cabrera, Jorge Moncayo-Rizzo, Karen Cevallos, Geovanny Alvarado-Villa. Waist Circumference as a Risk Factor for Non-Alcoholic Fatty Liver Disease in Older Adults in Guayaquil, Ecuador. Geriatrics 2023; 8(2): 42 doi: 10.3390/geriatrics8020042
421
Arash Gholoobi, Mehrnoosh Gifani, Aida Gholoobi, Saeed Akhlaghi, Masoud Pezeshki Rad, Vafa Baradaran Rahimi. Relationship between the prevalence and severity of non‐alcoholic fatty liver disease and coronary artery disease: Findings from a cross‐sectional study of a referral center in northeast Iran. JGH Open 2022; 6(5): 330 doi: 10.1002/jgh3.12746
422
Adrian T. Billeter, Sarah Wloka, Rouven Behnisch, Thomas Albrecht, Stephanie Roessler, Benjamin Goeppert, Sebastian Mueller, Felix Nickel, Beat Müller. Development and Validation of a Novel Scoring System for Noninvasive Nonalcoholic Steatohepatitis Detection in Bariatric Patients. Obesity Facts 2021; 14(5): 490 doi: 10.1159/000517383
423
Long Le, Ravina Kullar, Hussein M. Saleh, Sammy Saab. Preferred Noninvasive Testing for Nonalcoholic Steatohepatitis. Digestive Diseases and Sciences 2020; 65(12): 3719 doi: 10.1007/s10620-020-06382-4
424
Aunchalee Jaroenlapnopparat, Thanitsara Rittiphairoj, Natapat Chaisidhivej, Bradley Walker, Nipith Charoenngam. High parathyroid hormone level as a marker of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: A systematic review and meta-analysis. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2023; 17(8): 102827 doi: 10.1016/j.dsx.2023.102827
425
Gieira S. Jones, Barry I. Graubard, Christian S. Alvarez, Katherine A. McGlynn. Prediction of nonalcoholic fatty liver disease using anthropometry and body fat measures by sex and race/ethnicity in the United States. Obesity 2022; 30(9): 1760 doi: 10.1002/oby.23514
426
Seth A. Waits, Kyle H. Sheetz, Amir A. Ghaferi. Considering Bariatric Surgery in Patients With Nonalcoholic Steatohepatitis—Worth the Risk. JAMA Network Open 2019; 2(2): e190053 doi: 10.1001/jamanetworkopen.2019.0053
427
Bertha Marin-Alejandre, Itziar Abete, Irene Cantero, Jose Riezu-Boj, Fermín Milagro, J. Monreal, Mariana Elorz, José Herrero, Alberto Benito-Boillos, Jorge Quiroga, Ana Martinez-Echeverria, Juan Uriz-Otano, María Huarte-Muniesa, Josep Tur, J. Martínez, M. Zulet. Association between Sleep Disturbances and Liver Status in Obese Subjects with Nonalcoholic Fatty Liver Disease: A Comparison with Healthy Controls. Nutrients 2019; 11(2): 322 doi: 10.3390/nu11020322
428
Fabian Seebacher, Anja Zeigerer, Nora Kory, Natalie Krahmer. Hepatic lipid droplet homeostasis and fatty liver disease. Seminars in Cell & Developmental Biology 2020; 108: 72 doi: 10.1016/j.semcdb.2020.04.011
429
Yaning Biao, Jian Chen, Chenxu Liu, Ruilong Wang, Xue Han, Li Li, Yixin Zhang. Protective Effect of Danshen Zexie Decoction Against Non-Alcoholic Fatty Liver Disease Through Inhibition of ROS/NLRP3/IL-1β Pathway by Nrf2 Signaling Activation. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.877924
430
Antonio Carlos Soares Pantaleão, Marcio Pinto de Castro, Krishynan Shanty Fernandes Meirelles Araujo, Carlos Frederico Ferreira Campos, André Luiz Alves da Silva, José Eduardo Ferreira Manso, João Carlos Machado. Ultrasound biomicroscopy for the assessment of early-stage nonalcoholic fatty liver disease induced in rats by a high-fat diet. Ultrasonography 2022; 41(4): 750 doi: 10.14366/usg.21182
431
Chunbao Mo, Tingyu Mai, Jiansheng Cai, Haoyu He, Huaxiang Lu, Xu Tang, Quanhui Chen, Xia Xu, Chuntao Nong, Shuzhen Liu, Dechan Tan, Qiumei Liu, Min Xu, You Li, Zhiyong Zhang, Jian Qin. Association between TFEB gene polymorphism, gene–environment interaction, and fatty liver disease: A case–control study in China. Science Progress 2021; 104(3): 003685042110437 doi: 10.1177/00368504211043766
432
Chanh-Phong Tran, John J Kim, Jordan J Feld, William WL Wong. Cost-effectiveness of obeticholic acid for the treatment of non-alcoholic steatohepatitis: An early economic evaluation. Canadian Liver Journal 2021; 4(4): 360 doi: 10.3138/canlivj-2021-0011
433
Rishi Rikhi, Tavankit Singh, Jamak Modaresi Esfeh. Work up of fatty liver by primary care physicians, review. Annals of Medicine and Surgery 2020; 50: 41 doi: 10.1016/j.amsu.2020.01.001
434
Haider Ghazanfar, Sameer D Kandhi, Iqra Nawaz, Nismat Javed, Minu C Abraham , Mohamed Farag, Jaydeep Mahasamudram, Vishwa B Patel, Faryal Altaf, Harish Patel. Role of Glucagon-Like Peptide-1 Receptor Agonists in the Management of Non-Alcoholic Steatohepatitis: A Clinical Review Article. Cureus 2021;  doi: 10.7759/cureus.15141
435
Ali Canbay, Nandita Kachru, Jennifer Scarlet Haas, Jan‐Peter Sowa, Dominic Meise, Ahmet Burak Ozbay. Patterns and predictors of mortality and disease progression among patients with non‐alcoholic fatty liver disease . Alimentary Pharmacology & Therapeutics 2020; 52(7): 1185 doi: 10.1111/apt.16016
436
Egor V. Kalinin, Yaroslava M. Chalenko, Elena V. Sysolyatina, Konstantin Y. Midiber, Alexey M. Gusarov, Olga I. Kechko, Alexandra A. Kulikova, Ludmila M. Mikhaleva, Andrey Ya. Mukhachev, Yaroslav M. Stanishevskyi, Vladimir A. Mitkevich, Konstantin A. Sobyanin, Svetlana A. Ermolaeva. Bacterial hepatocyte growth factor receptor agonist stimulates hepatocyte proliferation and accelerates liver regeneration in a partial hepatectomy rat model. Drug Development Research 2021; 82(1): 123 doi: 10.1002/ddr.21737
437
Renzo Pajuelo-Vasquez, Jerry K. Benites-Meza, Hilda V. Durango-Chavez, Gustavo Salinas-Sedo, Carlos J. Toro-Huamanchumo. Diagnostic performance of the GGT/HDL-C ratio for NAFLD in adults with obesity undergoing bariatric surgery. Diabetes Research and Clinical Practice 2024; 211: 111649 doi: 10.1016/j.diabres.2024.111649
438
Tudor Mocan, Dong Wook Kang, Billy J. Molloy, Hyeonho Jeon, Zeno A. Spârchez, Diren Beyoğlu, Jeffrey R. Idle. Plasma fetal bile acids 7α-hydroxy-3-oxochol-4-en-24-oic acid and 3-oxachola-4,6-dien-24-oic acid indicate severity of liver cirrhosis. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-87921-5
439
Kavita Jadhav, Taylor S. Cohen. Can You Trust Your Gut? Implicating a Disrupted Intestinal Microbiome in the Progression of NAFLD/NASH. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.592157
440
Mary McCallum, Pauline Dundas, Ashis Mukhopadhya. Multidisciplinary pathway to support lifestyle change: tangible benefits in physical and mental health for patients with nonalcoholic fatty liver disease (NAFLD). Clinical Liver Disease 2023; 21(2): 60 doi: 10.1097/CLD.0000000000000017
441
Kevin Craig, Marc Abrams, Mansoor Amiji. Cholesterol-Conjugated siRNA Silencing Tnf for the Treatment of Liver Macrophage-Mediated Acute Inflammation in Nonalcoholic Fatty Liver Disease. Nucleic Acid Therapeutics 2023; 33(1): 35 doi: 10.1089/nat.2022.0038
442
María Martín-Grau, Mercedes Pardo-Tendero, Pilar Casanova, Mar Dromant, Vannina G. Marrachelli, Jose Manuel Morales, Consuelo Borrás, Serena Pisoni, Sabrina Maestrini, Anna M. Di Blasio, Daniel Monleon. Altered Lipid Moieties and Carbonyls in a Wistar Rat Dietary Model of Subclinical Fatty Liver: Potential Sex-Specific Biomarkers of Early Fatty Liver Disease?. Antioxidants 2023; 12(10): 1808 doi: 10.3390/antiox12101808
443
Andrea Gonzalez, Mayalen Valero-Breton, Camila Huerta-Salgado, Oscar Achiardi, Felipe Simon, Claudio Cabello-Verrugio. Impact of exercise training on the sarcopenia criteria in non-alcoholic fatty liver disease: a systematic review and meta-analysis. European Journal of Translational Myology 2021;  doi: 10.4081/ejtm.2020.9630
444
Marta Flisiak-Jackiewicz, Anna Bobrus-Chociej, Natalia Wasilewska, Dariusz Marek Lebensztejn. From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—New Terminology in Pediatric Patients as a Step in Good Scientific Direction?. Journal of Clinical Medicine 2021; 10(5): 924 doi: 10.3390/jcm10050924
445
Huimin Zou, Ying Ge, Qing Lei, Carolina Oi Lam Ung, Zhen Ruan, Yunfeng Lai, Dongning Yao, Hao Hu. Epidemiology and disease burden of non-alcoholic steatohepatitis in greater China: a systematic review. Hepatology International 2022; 16(1): 27 doi: 10.1007/s12072-021-10286-4
446
Ya-Ping Huang, Shi Zhang, Minying Zhang, Yi Wang, Wen-Hong Wang, Jing Li, Chunjun Li, Jing-Na Lin. Gender-specific prevalence of metabolic-associated fatty liver disease among government employees in Tianjin, China: a cross-sectional study. BMJ Open 2021; 11(12): e056260 doi: 10.1136/bmjopen-2021-056260
447
Jae Hyun Yoon, Chung Hwan Jun, Jeong Han Kim, Eileen L. Yoon, Byung Seok Kim, Jeong Eun Song, Ki Tae Suk, Moon Young Kim, Seong Hee Kang. Changing Trends in Liver Cirrhosis Etiology and Severity in Korea: the Increasing Impact of Alcohol. Journal of Korean Medical Science 2021; 36(21) doi: 10.3346/jkms.2021.36.e145
448
M. A. Livzan, M. I. Syrovenko, T. S. Krolevets. Non-alcoholic fatty liver disease and the risk of malignant tumors. Meditsinskiy sovet = Medical Council 2023; (18): 75 doi: 10.21518/ms2023-355
449
Cindy X. Cai, Stella Carlos, Pejman Solaimani, Bansari J. Trivedi, Chuong Tran, Shobha Castelino-Prabhu. Dietary Interventions in Liver Disease. 2019; : 357 doi: 10.1016/B978-0-12-814466-4.00029-X
450
Laura Huiban, Anca Trifan, Carol Stanciu. Essentials of Non-Alcoholic Fatty Liver Disease. 2023; : 229 doi: 10.1007/978-3-031-33548-8_20
451
Karla Sawada Toda-Oti, José Tadeu Stefano, Ana Mercedes Cavaleiro, Flair José Carrilho, Maria Lúcia Correa-Gianella, Cláudia Pinto Marques de Souza de Oliveira. Association of UCP3 Polymorphisms with Nonalcoholic Steatohepatitis and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease Brazilian Patients. Metabolic Syndrome and Related Disorders 2022; 20(2): 114 doi: 10.1089/met.2020.0104
452
Jun-Hyuk Lee, Kyongmin Park, Hye Sun Lee, Hoon-Ki Park, Jee Hye Han, Sang Bong Ahn. Correspondence on Editorial regarding “Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations”. Clinical and Molecular Hepatology 2023; 29(1): 185 doi: 10.3350/cmh.2022.0375
453
Katie Shen, Achintya D Singh, Jamak Modaresi Esfeh, Jamile Wakim-Fleming. Therapies for non-alcoholic fatty liver disease: A 2022 update. World Journal of Hepatology 2022; 14(9): 1718-1729 doi: 10.4254/wjh.v14.i9.1718
454
Janus Ong, Khalid Alswat, Saeed Hamid, Mohamed El-Kassas. Nonalcoholic Fatty Liver Disease in Asia, Africa, and Middle East Region. Clinics in Liver Disease 2023; 27(2): 287 doi: 10.1016/j.cld.2023.01.014
455
Vinod K. Rustgi, You Li, Tina John, Carolyn Catalano, Mohamed I. Elsaid. Health Care Resource Use and Cost Burden of Chronic Kidney Disease in Patients With Chronic Liver Disease: A Real‐World Claims Analysis. Hepatology Communications 2020; 4(10): 1404 doi: 10.1002/hep4.1573
456
Michael G. Ross, Mina Desai. Genetic Disorders and the Fetus. 2021; : 214 doi: 10.1002/9781119676980.ch5
457
Camelia Munteanu, Betty Schwartz. The Effect of Bioactive Aliment Compounds and Micronutrients on Non-Alcoholic Fatty Liver Disease. Antioxidants 2023; 12(4): 903 doi: 10.3390/antiox12040903
458
Nigel S. Cook, Julie Cave, Anke-Peggy Holtorf. Patient Preference Studies During Early Drug Development: Aligning Stakeholders to Ensure Development Plans Meet Patient Needs. Frontiers in Medicine 2019; 6 doi: 10.3389/fmed.2019.00082
459
Dongxu Wang, Nan Nan, Hao Bing, Bing He. Controlled attenuation parameters to assess liver steatosis in obese patients with polycystic ovary syndrome. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1241734
460
Hilal Ahmad Mir, Roshia Ali, Umar Mushtaq, Firdous A. Khanday. Structure-functional implications of longevity protein p66Shc in health and disease. Ageing Research Reviews 2020; 63: 101139 doi: 10.1016/j.arr.2020.101139
461
Natalia Zhelezniakova, Iryna Tverezovska. Diagnostic and prognostic value of selenium and Selenoprotein P in patients with comorbid course of nonalcoholic fatty liver disease and arterial hypertension. Medicinski casopis 2022; 56(2): 68 doi: 10.5937/mckg56-36421
462
Gözde Arslanbulut, Seda Çiftçi. Exploring the link between fructose intake and Non-Alcoholic Fatty Liver Disease (NAFLD). Cahiers de Nutrition et de Diététique 2023; 58(6): 399 doi: 10.1016/j.cnd.2023.10.004
463
Hossein Saneian, Leila Khalilian, Motahar Heidari-Beni, Majid Khademian, Fatemeh Famouri, Peyman Nasri, Akbar Hassanzadeh, Roya Kelishadi. Effect of l-carnitine supplementation on children and adolescents with nonalcoholic fatty liver disease (NAFLD): a randomized, triple-blind, placebo-controlled clinical trial. Journal of Pediatric Endocrinology and Metabolism 2021; 34(7): 897 doi: 10.1515/jpem-2020-0642
464
Karn Wijarnpreecha, Melissa Scribani, Pascale Raymond, Denise M Harnois, Andrew P Keaveny, Aijaz Ahmed, Donghee Kim. PNPLA3 gene polymorphism and overall and cardiovascular mortality in the United States. Journal of Gastroenterology and Hepatology 2020; 35(10): 1789 doi: 10.1111/jgh.15045
465
Shahinul Alam, Md. Saiful Islam Alin, Farhana Begum, Shah Mohammad Fahim, Zareen Tasnim, Md. Mahabubul Alam. Estimating the cost of illness of non‐alcoholic fatty liver disease in Bangladesh. JGH Open 2023; 7(9): 629 doi: 10.1002/jgh3.12960
466
Yogesh Yadav, Wing-Kin Syn, Rita Basu. Evolving Management Strategies for Nonalcoholic Fatty Liver Disease–Targeting Primary Care Physicians. Diabetes Technology & Therapeutics 2019; 21(11): 611 doi: 10.1089/dia.2019.0158
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345